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Economic Impact of Mastitis in Dairy Cows 
Abstract 
This thesis aims to assess the economic loss associated with clinical (CM) and 
subclinical (SCM) mastitis under current Swedish farming conditions.  
Stochastic simulation was used to investigate the impact of mastitis on technical 
and economic results of a 150-cow dairy herd. The yearly avoidable cost of mastitis, 
assuming that the initial incidence (32 and 33 cases of CM and SCM per 100 cow-
years, respectively) could be reduced by 50%, was estimated at €8 095. This figure 
corresponded to 5% of the economic net return for the herd given the initial 
incidence of mastitis. Expressed as an average per cow/year, the avoidable cost of 
mastitis was estimated at €54.  
The economic loss associated with mastitis could not be reduced by discarding 
milk with high somatic cell count, because this resulted in a substantial decrease of 
the volume of sold milk which was not offset by the increase in milk price.  
Cases of CM and SCM were on average associated with an average economic 
loss of €275 and €60, respectively. Reduced milk production constituted the major 
cost component of the economic loss caused by mastitis.  
The magnitude of yield loss associated with mastitis occurring in different stages 
of lactation was assessed using mixed linear models. The dataset was collected in a 
research herd between 1987 and 2004, and consisted of weekly test-day records 
sampled in 1200 lactations. The most extensive yield loss was estimated when CM 
developed in early lactation and when SCM (modelled by means of increased 
somatic cell count) occurred in late lactation. The 305-day yield loss associated with 
CM varied between 0 and 705 kg milk in primiparous cows and between 0 and 902 
kg milk in multiparous cows, depending on lactation week at onset. Most cases of 
CM developed in the first week of lactation and resulted in a yield loss of 578 and 
782 kg milk in primiparous and multiparous cows, respectively. Daily yield loss at 
an SCC of 500 000 cells/ml ranged from 0.7 to 2.0 kg milk in primiparous cows 
and from 1.1 to 3.7 kg milk in multiparous cows. The yield loss in an average 305-
day lactation affected by SCM was 150 and 450 kg milk in primiparous and 
multiparous cows, respectively. 
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performance, discarding milk 
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Introduction 
The dairy sector is subjected to increasing international competition. 
Economically effective herds are thus a prerequisite to maintain a sound 
Swedish dairy industry. Economic margins of dairy herds are, however, 
narrow. Optimization of the economic results, therefore, becomes 
important, and the need for cost minimization at every level of production 
is accentuated. A means of reducing the costs of production is to decrease 
the incidence of production disorders, as such are associated with reduced 
production, veterinary costs, and increased replacement rate, and, 
consequently, give rise to economically less efficient herds. Mastitis is of 
considerable interest because of its high incidence and the extensive costs 
associated with the disease. In 2007, the average incidence of veterinary-
treated clinical mastitis (CM) in herds participating in the Swedish milk 
recording scheme was 16% (Swedish Dairy Association, 2008). The 
incidence of mastitis can however be expected to be even higher, because 
there is considerable under-reporting of CM (Mörk et al., 2009). Udder 
disease, including udder disorders and high somatic cell count (SCC), 
constitutes the most common reason for culling of Swedish dairy cows 
(Swedish Dairy Association, 2008). In 2007, 26% of cullings was attributed 
to udder disease, and 10% of the total cow population was, consequently, 
culled because of udder disorders and high SCC. Indeed, mastitis is the most 
costly disease in dairy production (Seegers et al., 2003 (review); Kossaibati & 
Esslemont, 1997; Degraves & Fetrow, 1993 (review)). 
Clearly, mastitis control is of paramount importance. The incidence of 
mastitis can be reduced by implementation of preventive measures. These 
are, however, associated with extra costs for the farmer in terms of 
investments and labour, and interventions will only be made if the resulting 
increase in revenue can be expected to offset the incurred costs. Information 
about the economic loss associated with mastitis is, therefore, crucial when   12
evaluating the viability of different preventive measures. The economic loss 
incurred by mastitis is also an essential part of other management decisions, 
such as treating infected udder quarters, culling mastitic cows, and discarding 
milk with high SCC in order to obtain a higher milk price.  
The frequency of mastitis in the dairy cow population can also be 
decreased by breeding for cows with better ability to resist udder disease. 
Udder health is unfavourably genetically correlated with milk yield (Carlén 
et al., 2004; Heringstad et al., 2000 (review); Emanuelson et al., 1988), and 
selecting only for increased production, which traditionally has been the 
focus of dairy cattle breeding in many countries, will therefore result in 
deterioration of udder health. This can be counteracted by applying a broad 
breeding goal, like the one used in the Nordic countries, which includes not 
only production traits, but functional traits such as mastitis resistance. The 
genetic progress in a trait is partly determined by the relative weight put on 
it in the total merit index of bulls. In order to assign proper economic 
weight to mastitis resistance, accurate estimates of the economic loss caused 
by mastitis are necessary.  
This thesis aims at assessing the economic loss associated with mastitis 
under current Swedish farming conditions, in order to provide estimates that 
can support decisions regarding mastitis control in individual herds and 
facilitate derivation of appropriate economic weight of mastitis resistance in 
the breeding goal. 
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Background 
What is Mastitis?  
Mastitis is defined as an inflammatory reaction of the mammary gland 
(International Dairy Federation, 1987). It is induced when pathogenic 
microorganisms enter the udder through the teat canal, overcome the cow’s 
defence mechanisms, begin to multiply in the udder, and produce toxins 
that are harmful to the mammary gland. Mammary tissue is then damaged, 
which causes increased vascular permeability. As a result of this, milk 
composition is altered: there is leakage of blood constituents, serum 
proteins, enzymes, and salts into the milk; decreased synthesis of caseins and 
lactose; and decreased fat quality (Østerås, 2000; Harmon, 1994). The extent 
of these changes is determined by the severity of the infection (Pyörälä, 
2003; Harmon, 1994; International Dairy Federation, 1987).  
Mastitis is a multifactorial disease. As such, its incidence depends on 
exposure to pathogens, effectiveness of udder defence mechanisms, and 
presence of environmental risk factors, as well as interactions between these 
factors (Oviedo-Boyso et al., 2007; Suriyasathaporn et al., 2000). 
Severity and Duration 
Mastitis can be either clinical or subclinical. Clinical cases give rise to visible 
symptoms. Mild CM causes flakes or clots in the milk, whereas severe cases 
are associated with heat, swelling and discolouration of the udder, as well as 
abnormal secretion. Severe CM can also exhibit systemic reactions, such as 
fever and loss of appetite. Mastitis can exist in the absence of visible signs of 
infection, and is then referred to as subclinical mastitis (SCM). SCM is the 
most prevalent form of mastitis (Akers, 2002). In practice, whether a case of 
mastitis is classified as clinical or subclinical often depends on how carefully 
the cow is observed when diagnosis is made (International Dairy Federation,   14
1987). SCM can be diagnosed by presence of pathogens in bacteriological 
cultures of milk, but bacteriological sampling is not practically feasible as a 
routine test. The current standard method of detecting SCM is to measure 
SCC. Other inflammatory parameters, such as electrical conductivity, 
lactose, lactate dehydrogenase, acute phase proteins, etc. (Åkerstedt et al., 
2007; Hamann, 2005; Pyörälä, 2003), have been proposed as indicators of 
SCM, and some have the potential of being adapted to in-line use.  
The duration of infection further classifies mastitis as acute or chronic 
manifestations, where a sudden onset defines acute cases and chronic mastitis 
is characterized by an inflammatory process that lasts for months and results 
in progressive development of fibrous tissue (International Dairy Federation, 
1987; Jain, 1979). 
Somatic Cell Count 
Milk always contains a certain amount of somatic cells. These consist of 
various cell types, and their relative proportions depend on the health status 
of the udder. In a healthy lactating mammary gland, the major proportion of 
somatic cells is constituted by leukocytes (white blood cells) (Östensson et 
al., 1988). These are primarily macrophages and lymphocytes, but a small 
fraction consists of neutrophils and epithelial cells (Harmon, 1994; Kehrli & 
Shuster, 1994). Microbial infection results in rapid accumulation of large 
numbers of somatic cells in the udder, and these are predominantly 
neutrophils (Harmon, 1994; Kehrli & Shuster, 1994; Östensson et al., 1988). 
The increase in SCC constitutes an important part of the cow’s immune 
response, and SCC is, therefore, a widely used indicator of mastitis.  
Infection status has been recognized as the main factor affecting SCC 
(Schepers et al., 1997; Sheldrake et al., 1983; Dohoo & Meek, 1982), and 
SCC often exceeds 1 000 000 cells/ml in milk produced by mastitic cows 
(Kehrli & Shuster, 1994). Compositional changes of milk are, however, 
significant from 100 000 cells/ml, and are observed already at an SCC as 
low as 50  000 cells/ml (Hamann, 2002; Reichmuth, 1975). In 
bacteriologically negative milk cultures of udder quarter foremilk, an 
average SCC of 68 000 cells/ml has been reported (Djabri et al., 2002).  
Laevens et al. (1997) found an SCC of 49 000 cells/ml in composite milk 
sampled in lactations from which no pathogens had been isolated. Presently, 
an SCC threshold of 100 000 cells/ml in quarter foremilk is internationally 
accepted (Hamann, 2005; 2003). In composite milk, an SCC above 50 000 
cells/ml is considered indicative of SCM (Hortet & Seegers, 1998a 
(review)).    15 
Pathogens  
The magnitude of increase in SCC partly depends on the causative 
pathogen (Djabri et al., 2002; Lam et al., 1997; Schepers et al., 1997). The 
primary mastitis causative microorganism is bacteria. These have 
traditionally been categorized into major or minor pathogens, depending on 
the magnitude of inflammatory response associated with infection. Major 
pathogens most often cause CM (Djabri et al., 2002), and give rise to the 
most extensive changes of milk composition (Harmon, 1994). These 
infections are most often due to Staphylococcus aureus, Streptococci (agalactiae, 
dysgalactiae, uberis),  Escherichia coli and  Klebsiella  spp. Minor pathogens, 
including Corynebacterium bovis and coagulase-negative staphylococci, cause 
only moderate infection and are most often associated with SCM (Djabri et 
al., 2002; Harmon, 1994). These pathogens have been reported to have a 
protective effect against major pathogens (Lam et al., 1997; Matthews et al., 
1991), and the reason has been suggested to be competitive growth, 
antagonism, induced leukocytosis or an increased immunity of the cow 
(Black et al., 1972). 
Depending on the vector of transmission, bacteria are considered either 
contagious or environmental pathogens. Staph. aureus and Strep. agalactiae are 
contagious pathogens, for which udders of infected cows serve as the major 
reservoir. Contagious pathogens spread from cow to cow, primarily during 
milking, and tend to result in chronic subclincal infections with flare-ups of 
clinical episodes (Harmon, 1994). Environmental pathogens include E. coli, 
Klebsiella  spp.,  Strept. dysgalactiae and Strept. uberis., and have bedding, 
manure and soil as their primary sources. The majority of infections caused 
by environmental pathogens are clinical and of short duration (Harmon, 
1994). 
In Sweden, the most common pathogens isolated in cases of CM are 
Staph. aureus, Strept. dysgalactiae, and E. coli (Persson Waller et al., 2009). 
Risk Factors 
Several features of individual cows can be identified, which might indicate 
an increased risk of developing mastitis.  
Multiparous cows are generally at higher risk of developing CM (Rajala-
Schultz et al., 1999b; Emanuelson et al., 1993; Bendixen et al., 1988), except 
in the very early stages of lactation where the relationship is the opposite 
(Steeneveld et al., 2008; Barkema et al., 1998). In multiparous cows, the risk 
of developing CM increases with increasing parity (Steeneveld et al., 2008). 
There is also consistency in the literature as regards higher SCC in older 
cows (Harmon, 1994; Reneau, 1986; Dohoo & Meek, 1982).    16
The risk of developing CM is highest in early lactation (Persson Waller et 
al., 2009; Steeneveld et al., 2008; Barkema et al., 1998), whereas the risk of 
SCM increases with increasing days in milk (Busato et al., 2000).  
Mastitic cows tend to have higher milk yield than non-mastitic cows 
before they develop CM (Gröhn et al., 2004; Wilson et al., 2004; Rajala-
Schultz et al., 1999b), indicating that high milk yield is a risk factor for CM. 
Previous occurrences of mastitis, CM or high SCC, substantially 
increased the risk of a cow developing a new case of CM (Steeneveld et al., 
2008; Bendixen et al., 1988). Other disorders, such as dystocia; milk fever; 
retained placenta; metritis; ketosis; and lameness, are also known to increase 
the risk of CM (Svensson et al., 2006; Emanuelson et al., 1993; Gröhn et al., 
1990b; Bendixen et al., 1988). 
Cows of certain breeds are more prone to mastitis. Among the Swedish 
breeds, national statistics (Swedish Dairy Association, 2008), as well as 
several studies (Persson Waller et al., 2009; Nyman et al., 2007; Emanuelson 
et al., 1993), show that Swedish Red cows have a lower incidence of 
mastitis than Swedish Holstein cows.  
The incidence of mastitis is influenced by managerial and environmental 
factors, such as housing of cows, milking equipment, feeding regime, 
hygienic quality of feed and water, cleanliness of cows, implementation of 
preventive measures, and general practices related to, for instance, drying-off 
(Nyman et al., 2007; Schreiner & Ruegg, 2003; Peeler et al., 2000; Barkema 
et al., 1999; Elbers et al., 1998). Season also affects the incidence of mastitis, 
and the incidence of CM has been reported to be highest during the winter 
months (Steeneveld et al., 2008; Olde Riekerink et al., 2007a; Bendixen et 
al., 1988).  
Consequences of Mastitis 
Mastitis is of great economic importance to milk producers, because the 
disease has negative impact on several important aspects of cow and herd 
performance. Incurred costs are of both direct and indirect nature 
(Kossaibati & Esslemont, 1997). Direct costs include veterinary costs, 
increased labour requirement, discarded milk (during the course of 
treatment), and reduced milk yield and quality. Indirect costs are those that 
are not always obvious to the milk producer, and are therefore referred to as 
hidden costs. They include increased risk of subsequent disorders, reduced 
fertility (extra services per conception and, as a result of this, an extended 
calving interval), increased risk of culling, and, occasionally, mortality. The 
total cost of mastitis can, consequently, be much higher than the direct cost   17 
(Kossaibati & Esslemont, 1997). The cost associated with each component is 
likely to vary between herds; partly because of differences in performance 
parameters (yield level, fertility, etc.) and partly because of different 
preferences of farmers influencing, for instance, their inclination to contact a 
veterinarian when mastitis is detected. 
Yield Loss  
The extent of yield loss depends on severity, causative pathogen, parity of 
cow, and the stage of lactation at which mastitis develops. In primiparous 
cows, yield loss is most severe when CM is caused by Staph. aureus, E. coli, 
and Klebsiella spp., whereas, in multiparous cows, Streptococcus spp., Staph. 
aureus, E. coli, Klebsiella spp., and A. pyogenes are responsible for the largest 
yield loss (Gröhn et al., 2004). Multiparous cows suffer more severe yield 
loss than primiparous cows (Bennedsgaard et al., 2003; Hortet et al., 1999; 
Rajala-Schultz et al., 1999b). CM occurring before peak yield results in the 
most extensive yield loss (Rajala-Schultz et al., 1999b; Hortet & Seegers, 
1998b (review)), whereas SCM occurring in late lactation is associated with 
the highest yield loss (Bennedsgaard et al., 2003; Hortet et al., 1999).  
There is substantial variation as regards estimates of the magnitude of 
lactational yield loss in the literature. Discrepancies are due to differences in 
management, breed and yield level, as well as the analytical method used.  
CM is associated with yield loss at the time of diagnosis, and, more 
importantly, yield loss often persists throughout lactation (Wilson et al., 
2004; Rajala-Schultz et al., 1999b; Houben et al., 1993). In the latest review 
on the subject, Hortet and Seegers (1998b) summarised a lactational yield 
loss of 300 to 400 kg (4 to 6%) in multiparous cows and 200 to 300 kg in 
primiparous cows. Cases of CM are of different severity, and 40% of CM 
cases can be expected to be associated with negligible yield loss, 30% with a 
lactational yield loss of 150 ± 250 kg, and 30% with a lactational yield loss 
of 950 ± 1050 kg (Hortet & Seegers, 1998b). Before diagnosis, mastitic 
cows have a production advantage over their non-mastitic herd mates 
(estimated at 2.6 kg by Wilson et al. (2004)). As most studies use the yield 
level of non-mastitic cows as reference for yield in healthy cows, the 
reported losses probably underestimate the true yield loss associated with 
CM.  
The reduction in milk yield associated with SCM has been summarised 
as 80 kg (1.3%) and 120 kg (1.7%) per 2-fold increase in SCC above 50 000 
cells/ml in primiparous and multiparous cows, respectively (Hortet & 
Seegers, 1998a).    18
The economic damage caused by yield loss is to some extent alleviated 
by reduced feed cost (Yalcin, 2000). This effect of local CM is small, but 
systemic CM has been reported to reduce dry matter intake by 30 kg over a 
period of 117 days (Bareille et al., 2003). Still, reduced milk yield is the 
major component of the cost associated with both CM and SCM (Huijps et 
al., 2008; Hortet & Seegers, 1998b (review); Degraves & Fetrow, 1993 
(review)). 
Milk Composition 
Mastitis decreases the synthetic capacity of the mammary gland, which leads 
to decreased concentrations of fat and caseins in the milk (summarized by 
Pyörälä, 2003 and Akers, 2002). Indeed, in reviews by Hortet & Seegers 
(1998a; 1998b) CM and SCM were found to cause somewhat lower fat 
content in the milk, and, on lactational level, estimates of the absolute fat 
yield loss due to CM varied between 3 and 22 kg (1.5 to 7.5%). Results 
from previous studies indicate slightly increased protein content in milk 
produced by mastitic cows (Hortet & Seegers, 1998a; 1998b). This is due to 
a higher content of inflammatory, non-coagulating proteins and whey 
proteins, but, at the same time, a decreased proportion of casein (Urech et 
al., 1999; Auldist et al., 1996; Barbano et al., 1991). In the studies reviewed 
by Hortet & Seegers (1998b), the absolute protein yield loss following a case 
of CM ranged from 0 to 15 kg (0 to 8.5%). Milk composition changes 
caused by mastitis can be neglected in economic calculations (Seegers et al., 
2003), because milk produced in connection with diagnosis is discarded due 
to treatment and later losses are proportional to the milk loss. 
The bacterial count is increased by mastitis, but the elevation can be 
neglected after the withdrawal period (Seegers et al., 2003). 
The only changes in milk composition that are of economic importance 
to the dairy producer are those that affect the milk price, i.e. components 
that are part of the milk payment scheme. The largest dairy association in 
Sweden, Arla Foods, pays a premium when bulk tank somatic cell count 
(BTSCC) is below 300 000 cells/ml, and incurs a penalty when BTSCC 
exceeds 401 000 cells/ml. In a specific herd, the bulk tank SCC and the 
amount of milk produced influence whether a single case of mastitis will 
affect the milk price or not, because those factors impact on the extent to 
which the milk from the mastitic cow is “diluted” in the bulk tank (Østerås, 
2005).  
In practice, if BTSCC has been too high for a period of time, a cow with 
high SCC might be culled in order to bring down BTSCC and avoid 
payment penalties. Culling does, however, incur a cost of replacement, and   19 
might, in fact, be more costly than accepting milk quality penalty (Dekkers 
et al., 1996). An alternative approach to reduce BTSCC and limit the 
impact of mastitis on herd profit is to sort out milk with high SCC. Milk-
sorting decisions have traditionally been based on SCC information 
obtained from the milk recording scheme. Such information is obtained on 
a monthly basis, resulting in crude decisions. Recent technological 
advancements now allow SCC to be recorded in-line, and thus provide 
means to make decisions on whether or not the milk from a certain cow is 
to be delivered to the dairy in connection with each milking. The 
profitability of discarding poor quality milk based on the results of an in-line 
SCC indicator can, however, be expected to depend on how accurately 
SCC can be recorded. If uncertainty is high, there would be a risk of 
classifying milk with low SCC as poor quality milk and discard it and vice 
versa, resulting in lower economic benefit of discarding milk with high SCC 
as compared to if the true SCC could be measured. 
Veterinary and Treatment Costs 
In Sweden, only veterinarians may prescribe drugs for treatment of mastitis. 
Milk producers consulting a veterinarian for treatment of a case of CM are, 
on average, charged €119
1 (1 200 SEK, exchange rate of 18 November 
2008, Paper IV) for starting fee, travel costs, labour, and drugs. Veterinary 
costs are partly subsidised in Sweden. 
Veterinary costs are easily identified, and are often perceived by farmers 
as the full cost of mastitis. In a study of Norwegian dairy herds, it has, 
however, been shown that there is only marginal association between 
treatment rate of mastitis and gross margin, indicating that treatment costs 
constitute only part of the total cost of mastitis and that most costs are 
hidden (Østerås, 2000). Østerås (2000) therefore suggested that treatment 
costs should be regarded as an investment to decrease the hidden costs. 
Discarded Milk 
Milk produced when a cow shows signs of mastitis, or while a cow is 
treated with antibiotics, is discarded. The withdrawal period includes the 
days when a cow actually receives drugs and a waiting time, usually 
consisting of some additional days, when there is a risk of antibiotic residues 
in the milk. The length of the withdrawal period depends on the 
production system (i.e. conventional or organic), and the drug used. 
The cost of discarded milk is comparable to that of milk loss, but with 
one important difference: discarded milk is produced by the cow and is 
                                                  
1Thomas Svensson, Swedish Board of Agriculture, personal communication   20
therefore associated with feed costs. The cost per unit of discarded milk is 
thus higher than the corresponding cost of milk not produced (Halasa et al., 
2007; Hogeveen & Østerås, 2005).  
Some herds feed discarded milk to calves, and, when this is practised, 
discarded milk should be assigned an alternative value corresponding to that 
of the amount of milk replacer that would otherwise have been needed. 
Feeding milk produced by mastitic cows or cows being treated with 
antibiotics to calves is, however, not recommended by Swedish 
veterinarians. 
Extra Labour 
CM is associated with extra labour requirement, for instance in form of 
attendance of the visit by the veterinarian and administration of medicine. 
Also, CM may affect the order in which cows are milked, and thus gives rise 
to less efficient milking routines. The time requirement associated with a 
case of CM is likely to amount to two hours
2. The amount of time needed 
to treat SCM can be expected to be less than that associated with CM, 
because SCM is not always detected, and, when detected, is not always 
treated.  
Extra labour requirement should be valued based on the opportunity cost 
of labour, i.e. the value of the next best alternative foregone as the result of 
having to assign time to mastitis. Opportunity cost of labour in agriculture is 
often difficult to assess, and is likely to differ between farms (Halasa et al., 
2007; Hogeveen & Østerås, 2005). Opportunity cost is readily calculated if 
labour is of external source; because the value of time spent on preventing 
mastitis can be estimated as hours times hourly wage. If labour is of internal 
source, i.e. the farmers own time, opportunity cost is zero, or the value that 
the farmer assigns to his or her free time. If, however, the farmer spends less 
time on other tasks consequential upon having to deal with mastitis, then 
opportunity cost is the decreased income resulting from spending less time 
on these other tasks. 
Subsequent Disorders 
Cows having experienced one case of CM often develop a subsequent case 
of CM later in lactation (Rajala & Gröhn, 1998; Houben et al., 1993). Also, 
as contagious pathogens use the udder of infected cows as reservoir, having 
mastitic cows in a herd increases the risk of spreading infection to healthy 
cows. Mastitis is associated with increased risk of lameness (Peeler et al., 
1994; Dohoo & Martin, 1984a), and CM has been reported to be associated 
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with concurrent or subsequent diagnosis of ketosis, displaced abomasum, 
and non-parturient paresis (Gröhn et al., 1989). CM is not a risk factor for 
reproductive disorders (Gröhn et al., 1990a), but both CM and SCM are 
known to adversely affect reproductive performance (Petersson et al., 2006; 
Maizon et al., 2004; Schrick et al., 2001). 
When other disorders or fertility disturbances occur as a consequence of 
mastitis, it has been argued that their economic cost should be included in 
the total cost of mastitis (Halasa et al., 2007; Hogeveen, 2005). A 
complicating factor is, however, that the causative relationships between 
mastitis and other disorders are somewhat obscure, and care must, therefore, 
be taken in assigning costs of other disorders to mastitis as this might result 
in overestimation of the total cost of mastitis.  
Culling 
CM increases the risk of culling (Schneider et al., 2007; Rajala-Schultz & 
Gröhn, 1999a; Gröhn et al., 1998), as well as mortality (Bar et al., 2008a). 
The extent to which CM affects the risk of culling depends on lactation 
stage at clinical onset (Schneider et al., 2007; Beaudeau et al., 1995; Dohoo 
& Martin, 1984b). It is also influenced by reproductive status, and open 
cows are at greatest risk of being culled due to CM if they are diagnosed in 
early lactation, whereas, pregnant cows are subjected to a relatively similar 
risk of being culled because of CM irrespective of when in lactation they are 
diagnosed (Schneider et al., 2007). Once cows are pregnant, the risk of 
being culled as a consequence of CM drops sharply (Gröhn et al., 1998). 
SCC above 300  000 cells/ml has been reported to increase the risk of 
culling in primiparous cows (Beaudeau et al., 1995), and, in late lactation, 
SCM is the most important disease influencing culling decisions regardless of 
parity of the cow (Dohoo & Martin, 1984b). 
The cost associated with involuntary culling as a consequence of mastitis 
is an important component of the total cost of mastitis. Like milk loss, 
increased risk of culling imposes a hidden cost, which is not always obvious 
to the farmer. Involuntary cullings are associated with replacement costs, 
and hence include costs of rearing or buying a heifer. If a heifer is not 
available at the time a cow is culled, capacity utilization is reduced as a stall 
will be empty while the fixed costs remain the same. Further economic loss 
can be expected as milk yield of primiparous cows is lower than that of 
multiparous cows, and because there is a risk that the yield level of a heifer 
might be disappointing (Halasa et al., 2007; Hogeveen, 2005; Østerås, 
2005). Economic cost also arise as cows culled due to mastitis do not reach 
their full production potential (Østerås, 2005). On the other hand,   22
additional returns from meat are obtained if a mastitic cow can be sold to 
slaughter.  
Economic assessment of the impact of increased risk of culling is not 
straightforward. Culling results from a management decision taken by the 
farmer, which is based not only on presence or absence of mastitis but also 
on milk yield, pregnancy status, parity, stage of lactation, and presence of 
other diseases (Gröhn et al., 1998). Cows are culled when replacement is 
judged to be the economically optimal alternative. At what point in time it 
is optimal to replace a mastitic cow is, indeed, determined by the above 
mentioned factors (Houben et al., 1994). Furthermore, it also depends on 
mastitis incidence and critical price parameters (Stott & Kennedy, 1993).  
Other Effects 
Any kind of pathology involves some degree of poor animal welfare 
(Broom, 2006). Mastitis is a very painful condition and is one of the major 
welfare problems of dairy cows (Broom & Fraser, 2007; Webster, 1999). 
Even mild cases of CM cause increased responsiveness to pain and affected 
cows become hypersensitized to stimuli normally considered innocuous 
(Fitzpatrick et al., 1998).  
In European countries, there is a high level of consumer concern for 
animal welfare (Harper & Henson, 2001; Moynagh, 2000), which results in 
major public demand for improvements in animal welfare. Indeed, 
consumers are prepared to pay considerably more for welfare-friendly 
production practices (Moynagh, 2000). If milk is produced from cows with 
high incidence of mastitis, consumers’ acceptance of dairy production, and 
thereby their willingness to buy dairy products, may be adversely affected.  
There are no known, direct threats to public health associated with 
consuming dairy products made from high SCC milk (Hogan, 2005). 
Potential food safety risks do, however, arise from ingestion of human 
pathogens, bacterial toxins, and antibiotic residues; factors that are associated 
with high SCC in milk (Hogan, 2005).  
Mastitis in cattle is the main reason for use of antibiotics in Swedish 
animal production (Swedish Board of Agriculture, 2008b). Exposure of 
animals to antibiotics is an important factor contributing to development of 
resistant bacteria (Mevius et al., 2005), which is considered to be one of the 
major public health threats.    23 
Economic Assessment of Mastitis 
The total economic cost of disease consists of two distinct components; 
production loss and control expenditures (McInerney et al., 1992). Losses 
include benefits that are taken away and benefits that are not realized. The 
former can be exemplified by milk that must be discarded following 
treatment with antibiotics and the latter by milk that is never produced as a 
result of disease. Expenditures are extra inputs needed to limit losses, either 
by reducing the impact of an unplanned event, such as treatment of a 
mastitic cow, or by preventing such events from occurring, as in the case of 
investments into preventive measures. I t  h a s  b e e n  a r g u e d  t h a t  i t  i s  t h e  
relationship between losses and expenditures that is of importance if 
estimates of the cost of disease are to be used as input in decision-making 
(McInerney et al., 1992), not the economic loss associated with disease per se 
(Østerås, 2005; Dijkhuizen et al., 1995; Schepers & Dijkhuizen, 1991).  
The primary purpose of economic analyses is to support decisions 
regarding mastitis control. The economic losses in situations where nothing 
is done to limit the impact of mastitis should, therefore, be compared with 
the economic loss in situations where mastitis control is practised 
(Hogeveen, 2005). When such assessments reveal that mastitis management 
is economically profitable, interventions can be justified. Mastitis control can 
be practiced at different levels; udder quarter, cow, herd, or national. The 
cost of mastitis can be estimated at all of these levels, and the level of choice 
depends on the nature of the decision that is to be supported.  
At udder-quarter level, decisions are concerned with whether or not to 
dry off an infected udder quarter. Cow-level decisions are directed at 
managing occurrences of mastitis, and the options are no treatment, 
treatment or culling. Treatment decisions impact also on herd level, as 
treatment reduces spread of infection to healthy cows. In the same way, 
culling might serve to reduce the overall incidence of mastitis in the herd. 
Mastitis control at herd level aims at reducing the incidence of mastitis, and 
consists of various proactive and reactive measures. Information on the 
national consequences of mastitis is needed to answer whether subsidized 
veterinary services and targeted research are necessary in order to reduce the 
incidence of mastitis. Other contexts in which estimates of the impact of 
mastitis is essential are when milk payment schemes are designed to motivate 
producers to produce milk of desired quality, and when breeding programs 
are dimensioned with respect to mastitis resistance.  
The economic viability of different measures to control mastitis can only 
be assessed if reliable estimates of the economic loss brought about by the 
disease are available (Seegers et al., 2003). Before management strategies are   24
compared, the magnitude of economic loss must be addressed (Hogeveen, 
2005), because mastitis management needs to be based on insight into the 
costs associated with CM and SCM (Hogeveen & Østerås, 2005). Huirne 
(2003) emphasized that calculations of the economic loss resulting from 
mastitis is central, as they aid in providing a better overall view of the 
impact of the disease, as well as contribute to better understanding of the 
extent to which the loss can be reduced. It is the latter, the avoidable cost, 
that is of importance in mastitis control, because complete elimination of 
disease is not feasible (McInerney et al., 1992) and calculation of the 
economic loss against a situation with zero incidence would thus encourage 
overestimation of the economic damage associated with mastitis. 
Previous estimates of the cost of mastitis show large variation (reviewed 
by Halasa et al., 2007; Degraves & Fetrow, 1993; and Schepers & 
Dijkhuizen, 1991). Some reasons for this variation seem to be origin of data, 
definition of mastitis, differences in sources of loss included, and analytical 
approach applied. Furthermore, studies have been conducted in different 
spatiotemporal contexts, which can be assumed to influence the results as 
circumstances of production and price levels vary between countries and 
over time. Differences as regards the economic consequences of mastitis can 
also be expected between farms, because of differences in incidence of 
mastitis, pathogen frequency, severity of mastitis cases, number of cases per 
affected cow and management routines. Additionally, the impact of mastitis 
upon the economic performance of individual cows will be influenced by 
their production level, age and reproductive status, and this will, in turn, 
affect decisions regarding mastitis management on cow level (Hogeveen & 
Østerås, 2005). The external validity of results might, therefore, be 
questioned, and any generalizations must be made with caution. In order to 
support decisions regarding mastitis management in individual herds, 
evaluations of the economic loss associated with mastitis must be as specific 
as possible (Hogeveen, 2005; Hogeveen & Østerås, 2005). Preferably, they 
should be conducted for a specific herd and in a specific economic context 
(Seegers et al., 2003).  
The level at which the impact of mastitis has been estimated obviously 
affects the results. Even though it has been suggested that the herd-level cost 
of mastitis can be obtained by aggregating the costs at cow level (Østerås, 
2005), this might impose bias on the results. Several of the direct costs of 
mastitis, such as treatment, discarded milk, increased labour and decreased 
milk production, can readily be assessed in individual cows. Indirect 
consequences, however, frequently arise through herd dynamics, and often 
reflect management decisions taken by the farmer. Increased risk of culling   25 
and thus increased replacement costs, as well as penalties or loss of premiums 
connected with increased SCC in the bulk tank milk, are good examples of 
dynamic factors. The decision to cull a mastitic cow, in order to increase the 
average milk yield per cow and decrease BTSCC, incurs a replacement cost, 
and illustrates the way in which dynamics within the herd impact on herd-
level economy. Some herd-level effects can therefore not be assessed simply 
by summing up the cow-level effects, and this type of dynamics require the 
economic impact of mastitis to be addressed at herd level (Seegers et al., 
2003). 
Methods of Economic Analysis of Animal Disease 
There are several analytical approaches that can be applied in the assessment 
of economic effects of disease and disease control. Which one that is most 
suitable for a certain analysis depends on the nature of the decision problem; 
the complexity of the disease and its effects; the data available; the intended 
use of the model and the preferences and capabilities of the model builder 
and/or decision maker; and the resources available (Bennett, 1992). A brief 
description of the methods most frequently applied in economic analyses of 
the economic loss associated with mastitis is given below. 
Partial Budgeting 
Partial budgeting can be used for rather simplistic economic comparisons of 
different situations, such as high or low incidence of mastitis or changes 
associated with implementation of a new control measure. It is a marginal 
approach, i.e. it is concerned with changes in costs and returns due to an 
actual decision or a disease event. Consequently, the analysis considers 
variable costs (such as veterinary costs, labour, milk yield), but typically 
ignore fixed costs (for instance maintenance costs and interest). Establishing 
a partial budget requires information on: 
 
1.  Additional returns (returns that will not be received unless the 
change is undertaken) 
2.  Reduced costs (costs present in the initial situation that will be 
avoided if the change is made) 
3.  Returns foregone (returns received in the initial situation that will 
not be received if the change is made) 
4.  Extra costs (costs associated with the change that are not present in 
the initial situation)   26
If the sum of additional returns and reduced costs is greater than that of 
returns foregone and extra costs, the change can be economically justified.  
Advantages of using partial budgeting are that the method is a fairly 
uncomplicated and time effective. Drawbacks are that it cannot account for 
stochastic events nor involve development over time (Dijkhuizen et al., 
1995).  
Simulation 
Simulation is a more sophisticated method to analyse the impact of disease. 
A simulation model is a simplified mathematical model of the unit of 
concern (for instance a dairy herd), which can be manipulated by 
modification of input parameters and, thus, adjusted to various real-life 
situations. Simulation is well suited to investigate the impact of strategies 
before they are applied, or as an alternative to intervention studies where 
such would be time consuming or associated with great costs. Simulation 
models can be either static or dynamic. Static models do not include time as 
a variable, whereas dynamic models do. Dynamic models are, thus, capable 
of modelling the development of the system over time. Models are further 
classified as deterministic or stochastic. Deterministic models make definite 
predictions of quantities, whereas stochastic models account for uncertainty 
in the behaviour of the system (i.e. the same conditions can give different 
outcomes), and, thus, reflect biological variation.  
Dynamic and stochastic simulation models can account for complicated 
interactions, and are thus capable of mimicking the dynamics taking place in 
a dairy herd. Indeed, stochastic simulation has been suggested to be the most 
relevant method to use when studying the effects of disease in a system 
(Allore & Erb, 1999; Dijkhuizen et al., 1995). Disadvantages of stochastic 
simulations are that the methodology requires an extensive amount of input, 
lots of computational power, and is rather time consuming.  
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Aims of Thesis 
The overall aim was to assess the economic loss associated with mastitis 
under current Swedish farming conditions. More specifically, the objectives 
were to: 
 
  Estimate the yield loss associated with CM and SCM occurring in 
different stages of lactation 
  Assess the consequences of mastitis on the results of a dairy herd, 
and to estimate the economic gain following a reduction of the 
current incidence of mastitis 
  Investigate whether recognition that yield loss varies depending on 
when in lactation CM occurs results in an evaluation of the 
economic loss caused by CM that differs from that derived when 
the lactational timing of CM is ignored 
  Study the impact of discarding milk with high SCC on herd net 
return 
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Summary of Investigations  
Material and Methods 
Detailed descriptions of studied materials and applied methods are given in 
Papers I to IV. Here, a condensed version is presented. 
Data from Research Herd 
Papers I and III were based on test-day records collected at weekly intervals 
in the research herd of the Department of Animal Breeding and Genetics, 
Swedish University of Agricultural Sciences. Data sampled between 
September 1987 and April 2004 were available. Cows were of the Swedish 
Red and Swedish Holstein breeds, and had an average yearly production of 
8 900 and 10 600 kg milk, respectively, in 2004. The research herd was kept 
at two locations during the study period. Before 1992, the herd was kept on 
a farm with tie-stall housing. The current farm has a free-stall barn (n = 50) 
and a tie-stall barn (n = 50). All cows were milked twice daily. In 2004, the 
median BTSCC was 150 000 cells/ml. 
Cases of CM were detected by the milkers by presence of abnormal milk 
in the first milk streams or by signs of inflammation in one or more udder 
quarters. All cases were diagnosed by a veterinarian. Not all cases were 
necessarily treated. Treatment decisions were made according to a Standard 
Operating Protocol based on stage of lactation as well as possible designation 
for culling. Affected udder quarters were sampled and the milk cultured to 
determine the pathogens present. Additional samples were taken two and 
five weeks after a completed treatment. Milk samples for bacteriological 
culture were also taken from cows with composite milk SCC > 180 000 
cells/ml on two subsequent test days (TD). Furthermore, milk samples were 
routinely cultured from each udder quarter in the fourth week of lactation, 
as well as two weeks before a cow was dried off. From the autumn of 1997 
until the autumn of 2000, milk samples were also taken in the first week of   30
lactation. From 1993 to 2004, milk samples were taken from 1 560 udder 
quarters and 40% of the samples had positive cultures. Table 1 shows the 
pathogens present in the culture-positive milk samples. 
Table 1. Pathogens present in culture-positive milk samples (n = 624) taken from mastitic udder 
quarters as well as by routine (Paper I) 
Pathogen  Frequency (%)
Mixed culture  25
Staphylococcus aureus
1   10
Staphylococcus aureus
2  1
Coagulase-negative Staphylococci
1 12
Coagulase-negative Staphylococci
2  6
Streptococcus agalactiae  0
Streptococcus dysgalactiae  11
Streptococcus uberis  7
Other Streptococcus spp.  1
Escherichia coli  16
Klebsiella  5
Arcanobacterium pyogenes  3
Other pathogens  3
1Sensitive to penicillin 
2Resistant to penicillin 
The lactational incidence risk (lactations with at least one case of CM 
divided by the total number of lactations at risk) of CM was 19.9 and 28.9% 
in primiparous and multiparous cows, respectively (Paper I).  Cases of CM 
most often developed in the first week of lactation (Figure 1). The overall 
recurrence rate of CM was 23%, and the average number of cases per 
lactation was 1.3. 
The geometric mean SCC on TD free of CM was 55 000 and 95 000 
cells/ml in primiparous and multiparous cows, respectively (Paper III). 
Median-values of SCC on TD free of CM, sampled in different stages of 
lactation, are given in Table 2.  
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Figure 1. Number of cases of clinical mastitis in each week of lactation in 
primiparous and multiparous cows (Paper I). 
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Table 2. Median-values of somatic cell count (x 10
3 cells/ml) in different stages of lactation on test days 
free of clinical mastitis (Paper III) 
 Lactation  weeks 
 1-2  3-8  9-16  17-24  25-32  33-44 
Primiparous cows  133  46  35  37  43  59 
Multiparous cows  114  48  51  77  109  164 
Paper I was based on 38 535 test-day records sampled from 307 Swedish 
Red and 199 Swedish Holstein cows. Out of 1 192 lactations, 298 were 
affected by at least one case of CM. The first lactational incidence of CM, 
irrespective of causative pathogen, was studied.  
Test-day records without information on SCC were discarded in Paper 
III, leaving data sampled between November 1989 and April 2004 from 303 
Swedish Red and 194 Swedish Holstein cows. Two datasets were created. 
Dataset A excluded test-day records sampled on days where cows were 
affected by CM, and a case of CM was assumed to last for eight days 
following diagnosis. It comprised 36 117 test-day records collected in 1 155 
lactations. A subset of dataset A (dataset B) was created by excluding all 
lactations in which CM occurred. Dataset B contained 27 753 test-day 
records sampled in 863 lactations.  
Simulated Data 
The impact of mastitis on technical and economic results in a Swedish 150-
cow dairy herd was studied by means of simulation (Papers II and IV). 
Scenarios were simulated over ten (Paper II) and twenty (Paper IV) years, 
but only the average annual results from the latter half of the period was 
used in the analyses. For each scenario, 250 replicates were performed. 
The effect of mastitis on milk yield was not modelled in the same 
manner in the two studies. In Paper II, the effect of CM on milk yield was 
modelled directly (based on results from Paper I), and no effect of SCC on 
milk yield was included in the model. The estimated average economic loss 
per case of CM, therefore, included possible correlated effects of CM on 
SCM, because the drop in production some weeks prior to diagnosis as well 
as part of the lactation-long impairment of milk yield subsequent to CM, 
may be due to SCM. It, thus, expressed the total economic loss caused by 
mastitis in lactations where CM occurred. In Paper IV, we were interested 
in the entire effect of mastitis on herd economy, and thus modelled both 
CM and SCM. Because of programming considerations (mastitis is modelled 
as one trait with different severities in SimHerd), the effect of mastitis on 
milk yield was mediated primarily through its effect on SCC, i.e. as an   33 
indirect effect. Mastitis started to affect SCC on the day of diagnosis. Cases 
of CM were supplemented with a direct effect on milk yield, because it has 
been reported that CM gives rise to a larger yield loss than what can be 
explained simply by the increase in SCC (Bennedsgaard et al., 2003). In 
Paper IV, recurrent cases of mastitis were allowed to develop within the 
same lactation.  
In Paper II, results given the initial incidence of CM (26 cases per 100 
cow-years, first lactational incidence) were studied, together with the 
consequences of reducing the incidence of CM by 50% and 90% 
throughout lactation and the consequences of reducing the incidence by 
50% and 90% only before peak yield. Different approaches to model yield 
loss subsequent to CM were compared; a conventional modelling strategy - 
i.e. one employing a single yield-loss pattern irrespective of when, during 
the lactation, the cow developed CM - and a new modelling strategy in 
which CM was assumed to affect production differently depending on its 
lactational timing (based on the results obtained in Paper I). The effect of 
choice of reference level when estimating yield loss was investigated by 
combining the modelling strategies with two different reference levels; the 
potential yield of mastitic cows, had they not developed CM, and the yield 
of non-mastitic cows. 
The full effect of mastitis, including both CM and SCM, was estimated 
in Paper IV. In the initial scenario, a CM incidence of 32 cases per 100 
cow-years (multiple cases could occur within the same lactation), based on 
the incidence of CM in the research herd studied in Papers I and III, was 
modelled. According to the distribution between clinical and subclinical 
cases of mastitis in a study by De Haas et al. (2002), the probability of a case 
becoming clinical was assumed to be 47%. In the initial scenario, an 
incidence of SCM of 33 cases per 100 cow-years was, consequently, 
modelled. Herd results given the initial incidence of mastitis were studied, 
together with the consequences of reducing and increasing the incidence of 
mastitis by 50% and the consequences of modelling no CM while the 
incidence of SCM was kept constant, and vice versa.  
Paper IV also included an assessment of the economic benefit of 
discarding milk with high SCC in order to obtain a higher price for the 
delivered milk. This was done by comparing results obtained when no milk 
with high SCC was discarded with results given different strategies for 
deciding when sorting of milk was to be initiated. When the decision of 
whether to discard milk with high SCC was based on herd-level 
information, sorting of milk was initiated when bulk tank SCC exceeded 
220  000, 200  000 and 180  000 cells/ml, respectively, whereas when the   34
decision was based on cow-level information, milk was discarded when 
SCC in individual cow’s milk exceeded 1 000 000, 750 000, and 500 000 
cells/ml, respectively. The impact of uncertainty in the measurement of 
SCC on the consequences of discarding milk with high SCC was 
investigated by simulating different levels of uncertainty; high, low, or none. 
Statistical Approaches 
The effects of CM and SCC on test-day yield were estimated using mixed 
linear models in SAS 8.2 and 9.1, respectively (PROC MIXED, SAS 
Institute Inc., Cary, USA). Due to different shapes of their lactation curves, 
primiparous and multiparous cows were analyzed separately. Dependent 
variables in the models were test-day milk (Papers I and III), and fat and 
protein yield (Paper I). The general model used in Papers I and III included 
fixed effects of parity, breed, pregnancy status, year-season of calving, and 
various disorders. Additionally, fixed effects of season of test-day and 
housing system were included in Paper III. Variables with P-value ≤ 0.05 
were considered statistically significant and were kept in the final models. 
Model validation was conducted by visual examination of normal 
probability plots of residuals against standardized residuals (q-q plots). 
Yield loss associated with CM occurring in different stages of lactation 
(Paper I) was investigated by including an interaction term between a 
mastitis index and lactation stage in the general model. The mastitis index 
was used to distinguish between cows with and without CM, as well as to 
indicate time (test day) with respect to day of diagnosis. The clustered 
nature of test-days, and declining correlation between test-days as the time 
interval between them increased, were accounted for by specifying an auto-
regressive residual correlation structure within lactations (Paper I). Least-
squares means of the interaction term were used as estimates of daily yield in 
a certain week of lactation at a certain time with respect to diagnosis, and 
305-day yields were extrapolated from the daily estimates. Yield loss was 
expressed relative to the yield of non-mastitic cows. 
The association between SCC and daily milk yield in different stages of 
lactation in cows free of CM was investigated in Paper III. Fixed linear, 
quadratic and cubic regressions of log2-transformed and centered SCC were 
nested within lactation stage. The shape of the lactation curve was described 
by two fixed effects; lactation stage and weeks in milk. Moreover, a random 
regression, which modelled the deviation of individual lactations from the 
general lactation curve, was fitted. Daily milk yield at different SCC, in 
different stages of lactation, was calculated based on the estimated regression 
coefficients. Daily yield loss was expressed relative to milk yield on test-days   35 
free of SCM, defined as having SCC below 50 000 cells/ml in lactation 
weeks 2 to 44 and below 175 000 and 200 000 cells/ml, respectively, in 
primiparous and multiparous cows in the first week of lactation. Lactational 
(305-day) milk loss caused by SCM was calculated based on the regression 
coefficients. Affected TD were assigned SCC corresponding to the week-
specific geometric mean of TD with SCC above the thresholds, whereas 
healthy TD were assigned SCC corresponding to the week-specific 
geometric mean of TD with SCC below the thresholds. Lactational milk 
loss in an average lactation affected by SCM was obtained by comparing the 
sum of weekly yields in affected cows, weighted by the prevalence of SCM 
in each week of lactation, with the 305-day yield of healthy cows. 
The SimHerd Model 
SimHerd is a dynamic bio-economic model with stochastic elements. It 
simulates production and associated events in a dairy herd over time through 
weekly time-increments. The simulation unit in the model is the individual 
animal. Herd-level production is simulated through the changes in state and 
production of individual animals. The state of an animal in each week is 
defined by age, parity, lactation stage, milk yield, body weight, reproductive 
status (oestrus and pregnancy) and disease status. Discrete events, such as 
oestrus detection, conception, sex and viability of the calf, disease 
occurrences, non-voluntary culling and mortality, are triggered 
stochastically. The modelling of mastitis within a lactation in Paper IV is 
summarized in Figure 2. 
The impact of different scenarios on herd net return was evaluated by 
applying Swedish market prices to the results. A treatment cost of €119     
(1 200 SEK, exchange rate of 18 November 2008, Paper IV) per incidence 
of CM, including veterinary fees and antibiotics, was assumed in Paper IV. 
Results were expressed as averages of 250 replicates, and were analyzed by 
univariate ANOVA. Simultaneous pair-wise comparisons of scenarios were 
conducted using t-tests (P < 0.05). 
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Figure 2. A simplified description of the modelling of mastitis in SimHerd (Paper IV). Mastitis 
only affected culling indirectly (....). Subclinical mastitis (SCM*) could only occur after 
clinical mastitis (CM) if the yield loss incurred by SCM was higher than the current yield loss 
caused by the earlier occurrence of CM. There was no upper limit as regards the number of 
mastitis cases in a lactation (indicated with --- in the figure).  
Main Results 
Yield Loss caused by Mastitis 
The magnitude of the yield loss was affected by the stage of lactation in 
which the cow developed mastitis. CM gave rise to the most extensive yield 
loss when cows were diagnosed in early lactation (Paper I), whereas 
increased SCC caused greatest loss when it occurred in late lactation (Paper 
III). Multiparous cows generally suffered more severe yield loss than 
primiparous cows (Papers I and III). Cows developing CM generally had a 
higher initial milk yield than non-mastitic cows (Paper I). 
Daily milk yield tended to decline 2 to 4 weeks prior to CM, and, after a 
case of CM, milk yield was suppressed throughout lactation (Paper I). At the 
time of diagnosis, daily milk loss in primiparous cows was close to 5 kg in 
Paper I, whereas it ranged from 1 to 8 kg in multiparous cows. On test-days 
free of CM, daily milk loss at an SCC of 500 000 cells/ml was estimated at 
0.7 to 2.0 and 1.1 to 3.7 kg in primiparous cows and multiparous cows, 
respectively (Paper III). The higher figures applied to TD sampled in 
lactation weeks 33 to 44. In Paper III, an increase in SCC had a certain 
relationship with daily milk yield in primiparous cows irrespective of 
whether the cow developed CM in the lactation or not. In multiparous 
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cows, on the other hand, an increase in SCC was associated with a higher 
milk loss in lactations where the cow did not develop CM. 
The relative yield loss associated with CM occurring in different weeks 
of lactation is illustrated in Figure 3. On 305-day basis, primiparous cows 
affected by CM suffered a yield loss in the range of 0 to 705 kg (0 to 9%), 
depending on the week of lactation in which the cow was diseased (Paper 
I). The most severe yield loss occurred when primiparous cows developed 
CM in lactation week six. Most cases of CM occurred in the first week of 
lactation, and yield loss in primiparous cows diagnosed at this point in time 
amounted to 578 kg milk. In multiparous cows, lactational yield loss varied 
from 0 to 902 kg (0 to 11%). The highest yield loss applied to multiparous 
cows developing CM in lactation week three. When CM occurred in the 
first week of lactation, yield loss in multiparous cows was estimated at 782 
kg milk.  
In an average lactation affected by SCM, primiparous cows suffered a 
yield loss of 155 kg milk, which corresponded to 2% of their 305-day yield 
(Paper III). Milk yield of multiparous cows was substantially more affected, 
and, in an average lactation affected with SCM, yield loss in multiparous 
cows amounted to 445 kg milk (5%). 
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Figure 3. Proportional change in 305-day milk yield in primiparous and multiparous cows 
diagnosed with clinical mastitis in different weeks of lactation, expressed relative to milk yield 
of non-mastitic cows (Paper I). 
Economic Loss associated with Mastitis 
The maximum avoidable cost of CM (i.e. the increase in net return if the 
initial incidence could be reduced by 90%) in a Swedish 150-cow dairy herd 
was estimated at €14  504 per year (Paper II). In Paper IV, the yearly 
avoidable cost of mastitis (CM and SCM) in a herd of the same size was 
estimated at €8  095, under the assumption that the initial incidence of 
mastitis could be reduced by 50%. Assuming that the relationship between 
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mastitis incidence and herd net return was linear, which appeared to be the 
case in Paper II, this would correspond to a maximum avoidable cost of 
€14 571. The avoidable cost of mastitis estimated in Paper IV corresponded 
to 5% of the herd net return given the initial incidence of mastitis. Figure 4 
shows the changes in various cost items that resulted from the 50% 
reduction of the initial incidence of mastitis in Paper IV.  
Figure 4. Changes in various cost components as a consequence of a 50% reduction of the 
initial incidence of mastitis (Paper IV). 
When the economic consequences of CM were investigated, an average 
economic loss of €428 per case was arrived at (Paper II). In Paper IV, where 
the economic impact of CM and SCM were assessed simultaneously, an 
estimate of €275 was obtained. These figures are not comparable, because 
the estimate from Paper II accounts for correlated effects of CM on SCM, 
whereas the estimate from Paper IV does not. The average economic loss 
per case of SCM was estimated at €60 (Paper IV). 
The average economic loss per case of CM was only slightly affected by 
the strategy for modelling yield loss when mastitic cows’ own yield level, 
had they not developed CM, was used as the reference for production in 
healthy cows when the yield loss was estimated. When the same reference 
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level for yield in healthy cows was used, applying specific yield-loss patterns 
for different periods in lactation did not have any substantial impact on herd 
results, as compared to using just one yield-loss pattern irrespective of the 
lactational timing of CM. Neither did the modelling strategy affect the 
response to a reduction of the risk of CM. Differences between modelling 
strategies were more pronounced when yield of non-mastitic cows was used 
as the reference for production in healthy cows. 
Discarding Milk with High SCC 
Discarding milk with high SCC was never profitable, because sorting of 
milk generated a substantial amount of milk withdrawal that was not offset 
by a sufficient increase in milk price. The most negative impact of 
discarding milk with high SCC on net return per cow-year was, 
consequently, observed when high incidence of mastitis was simulated. Milk 
sorting based on SCC measured with low uncertainty reduced the amount 
of withdrawn milk, and thus had less negative effect on net return per cow-
year as compared with when SCC was measured with high uncertainty. 
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General Discussion 
 
It is generally accepted that mastitis is the most costly disease in dairy 
production. The results of this thesis clearly emphasize the economic 
importance of mastitis, and stress the need for strategies to limit the impact 
of the disease. In the following, the most important findings will be 
discussed in detail. 
Yield Loss caused by Mastitis 
Severity 
Clinical mastitis was associated with higher milk loss than SCM (Papers I 
and III). In primiparous cows, CM occurring in early lactation gave rise to a 
yield loss that was three times the size of the milk loss in an average lactation 
affected by SCM. In multiparous cows, the reduction in milk yield 
following CM in early lactation was twice as large as that estimated in an 
average lactation affected by SCM.  
CM is the more severe form of mastitis, and a higher yield loss resulting 
from CM as compared with SCM is, thus, a logic finding. CM is associated 
with a larger amount of affected udder tissue, which results in more severe 
udder damage with decreased synthetic capacity of the mammary gland as a 
consequence. 
Lactation Stage 
The timing of mastitis in lactation had profound impact on the magnitude 
of yield loss (Papers I and III). Milk yield in cows developing CM before 
peak yield was most severely affected (Paper I). Partly, this can be expected 
to be due to the effects of CM being experienced over a longer period of 
time. Udder-tissue damage caused by CM in early lactation will, thus,   42
suppress milk yield throughout lactation (in accordance with the findings in 
Paper I). Also, it may be speculated that CM in early lactation obstructs the 
differentiation of secretory cells, which takes place in this period and is 
responsible for the increase in milk yield until peak lactation (Capuco et al., 
2001), thus resulting in more severe reduction of milk yield. Another 
explanation of the high yield loss associated with early occurrences of CM is 
related to that, in this stage of lactation, milk yield is increasing. High 
production can cause impairment of the immune system due to metabolic 
stress (Knegsel et al., 2007). When cows are in negative energy balance, 
body fat is converted to ketone bodies, and hyperketonemia has been 
suggested to be one of the most important factors causing impairment of the 
udder defence mechanisms (Janosi et al., 2003; Suriyasathaporn et al., 2000). 
It is likely that the impaired immune system in cows in early lactation results 
in reduced ability to battle infection, which contributes to the more severe 
depression of milk yield associated with CM. Cows are in negative energy 
balance until approximately weeks 7 to 9 of lactation (Suriyasathaporn et al., 
2000), which coincides with the stage of lactation in which CM gives rise to 
the most extensive yield loss. 
Increased SCC had the most detrimental effect on milk yield in late 
lactation. It has been suggested (Hortet et al., 1999), that poorer udder 
health status, caused by increased exposure to pathogens, increased 
prevalence of infection, and subsequent permanent glandular damage from 
previous infections, is responsible for the higher milk loss associated with an 
increase in SCC in late lactation. In Paper III, this explanation was tested 
using a sub-dataset containing only test-day records sampled in lactations in 
which CM did not occur and that were not immediately preceded by a 
lactation affected by CM. The obtained regression coefficients were similar 
to those estimated in the original analyses, and it was, therefore, concluded 
that milk loss related to an increase in SCC was highest towards the end of 
lactation, irrespective of whether cows had a history of CM or not. A 
different explanation for the higher yield loss associated with high SCC in 
late lactation was proposed: the fact that the udder is in a catabolic state. 
The degenerative process taking place might influence both the udder’s 
ability to repair itself after infection and the compensatory ability of 
uninfected quarters. The compensatory ability of uninfected quarters has, 
indeed, been found to be lower in late than in early lactation (Hamann & 
Reichmuth, 1990). Hamann and Reichmuth (1990) argued that the 
potential for yield compensation is related to the number and activity of 
secretory cells, supporting the above reasoning.    43 
Parity 
Parity of the cow was another important determinant of the extent of yield 
loss caused by mastitis (Papers I and III). Multiparous cows consistently 
suffered more severe yield loss than primiparous cows. This might be 
explained by multiparous cows having a higher yield level, and that they, 
simply, have more milk to lose. The relative yield loss was, however, also 
larger in multiparous cows, which indicates that this is not the full 
explanation. It may be hypothesized that the immune system becomes less 
e f f i c i e n t  a s  c o w s  g e t  o l d e r ,  w h i c h  m i g h t  r e s u l t  i n  l e s s  c o m p l e t e  c u r e  o f  
mastitis, with more extensive tissue damage and more severe yield loss as a 
consequence. 
Production Level 
Cows that developed CM tended to have higher initial milk yield than cows 
without CM (Paper I). The fact that high-yielding cows are more likely to 
develop CM further adds to the economic damage of the disease, and might 
suggest that the estimates reported in Paper I possibly underestimated the 
actual yield loss caused by CM. In Paper I, yield loss was expressed relative 
to the production level of cows without CM. Cows that developed CM in 
lactation weeks 1 to 8 and 9+ produced 2.5 and 0.8 kg ECM per day, 
respectively, more milk than their non-mastitic herd mates prior to three 
weeks before diagnosis (Paper II). Considering that most cases of CM 
develop in early lactation, these figures correspond well with the production 
advantage of mastitic cows of 2.6 kg milk reported by Wilson et al. (2004). 
In view of this, it might actually be reasonable to assume that another 2.5 kg 
milk could be added to the daily yield loss estimated in Paper I without 
overestimating the yield loss caused by CM.  
Most cows in a herd are in second or later lactations. Considering that 
most CM cases occurred in multiparous cows (Paper I), and that the median 
SCC in later parts of lactation in multiparous cows was more than twice the 
size of that in primiparous cows (Paper III), it can be concluded that the 
majority of milk loss caused by mastitis in a herd is suffered by multiparous 
cows. Furthermore, most of this yield loss is likely to occur in early and late 
stages of lactation. 
Importance of Mastitis to Herd Profit 
The yearly avoidable cost of mastitis in a Swedish 150-cow herd, assuming 
that the initial incidence of mastitis could be reduced by 50%, corresponded 
to 5% of the herd net return in the initial situation (Paper IV). Mastitis was   44
thus of considerable importance to the economic performance of the herd, 
confirming findings of Hansson (2007) who reported that average milk 
production per cow-year and incidence of mastitis were the only significant 
indicators of economic efficiency in Swedish dairy herds among several 
investigated predictors (incidence of mastitis, average milk production per 
cow-year, average protein content of milk, average herd fertility, and 
involuntary culling rate).  
Main components of the increase in net return when the incidence of 
mastitis was reduced were increased income from milk sales, because of 
higher production per cow-year and higher milk price as a result of an 
increased proportion of delivered milk with an SCC below 200  000 
cells/ml, and reduced veterinary costs (Paper IV, Figure 4). When all cases 
of CM were eliminated, income from milk sales increased substantially more 
than when no SCM cases were modelled. Also, CM was always associated 
with veterinary costs, and, when all cases where eliminated, these costs were 
avoided. It is thus clear from Paper IV that CM is more influential on herd 
profit than SCM.  
Implications for Mastitis Control 
The impact of mastitis on herd-level economy can be reduced by various 
interventions, which are of proactive or reactive nature. Measures aiming at 
preventing new cases of mastitis from occurring include breeding, 
improvement of milking hygiene, implementation of post-milking teat 
disinfection, regular controls of the milking equipment, implementation of 
milking order, and improvement of bedding material. Antibiotic treatment 
protocols, dry cow therapy, and culling regimes are examples of actions that 
are taken in order to limit the impact of mastitis once it has occurred. 
D i s c a r d i n g  m i l k  w i t h  h i g h  S C C ,  i n  order to increase the price of the 
delivered milk, can also be regarded as a means to reduce the economic 
damage caused by mastitis. 
Prioritization between Cows 
The most extensive yield loss occurred in multiparous cows diagnosed with 
CM in early lactation. To make matters worse from an economic point of 
v i e w ,  m o s t  c a s e s  o f  C M  d e v e l o p e d  i n  t h i s  c a t e g o r y  o f  c o w s  ( P a p e r  I ) .  
Preventive measures should, therefore, focus on reducing the incidence of 
mastitis in multiparous cows at early stages of lactation. This can be 
attempted by enhanced mastitis control in primiparous cows, because cows   45 
that have suffered a previous case are at substantially increased risk of 
developing subsequent cases (Steeneveld et al., 2008; Bendixen et al., 1988). 
Economic Framework 
Mastitis control incurs additional costs for the milk producer in terms of 
investments and extra labour requirement. Estimates of the avoidable cost of 
mastitis, which expresses the maximum viable expenditure on preventive 
measures per year, are thus necessary to determine the amount of money 
that can be invested into mastitis control. In a Swedish 150-cow herd with 
initial incidences of CM and SCM of 32 and 33 per 100 cow-years, 
respectively, € 8 095 could be spent on mastitis control on a yearly basis, if 
that investment results in a 50% reduction of the incidence of mastitis (Paper 
IV). This amount of money equates to 1.2 hours of external labour per day 
(at a cost of €17.8 per hour (Agriwise, 2008), which can be spent on 
improving management routines. Alternatively, €57 000 could be invested 
in improved milking equipment which might contribute to better udder 
health status, or be invested in technical tools, such as an in-line SCC 
indicator, which would facilitate monitoring of udder health in the herd. 
The maximal investment is calculated by the annuity method, with an 
interest rate of 7% per year and a depreciation period of ten years.  
The costs associated with implementation of different preventive 
measures differ. Moreover, different preventive measures are not equally 
effective in reducing the incidence of mastitis. The profitability of a certain 
control strategy is thus determined by the difference between its cost and 
the value of the reduction in mastitis incidence that it can achieve. To 
further complicate matters, the efficiency of different approaches to control 
mastitis varies depending on milking system. For example, Yalcin et al. 
(1999) showed that dry-cow therapy reduced SCC in herds milking in 
parlour, but not in herds with tie-stalls. Further studies are therefore needed 
to answer which preventive measures are most appropriate in the context of 
a specific herd.  
Control expenditures arise as a consequence of a mastitis problem and 
should therefore be attributed to mastitis (McInerney et al., 1992). Thus, in 
order to obtain an estimate of the total economic cost of mastitis, costs of 
prevention should be added to the estimates of economic loss proposed in 
this thesis.   46
Different Estimates Support Decisions at Different Levels 
Mastitis control is practiced at different levels. The nature of the decision 
that is to be supported determines which estimate of the economic loss 
associated with mastitis that is of interest in a certain situation.  
Cow-level decisions most often concern which actions that should be 
taken after a case of mastitis has been confirmed. In this case, the economic 
loss per case is the most relevant estimate. The expected extent of yield loss 
must then be taken into consideration, because it constitutes the major 
component of economic loss caused by mastitis.  
The avoidable cost of mastitis at herd level is pertinent when the 
economic viability of mastitis control programs is to be assessed.  
When economic weights of traits in the breeding goal are calculated, it is 
the avoidable economic cost associated with mastitis per cow-year that is the 
most appropriate input. It can be debated whether yield loss should be 
included in the economic loss caused by mastitis in this context, because if 
yield loss is already part of the genetic evaluation for milk yield, i.e. the milk 
yield of an affected cow is considered her production potential, then 
including yield loss also when deriving the economic weight of mastitis 
would double-count this effect. Milk loss is, however, a consequence of 
mastitis, and neglecting it in the genetic evaluation might underestimate the 
economic importance of mastitis. 
Economic Loss per Case of Mastitis 
Inconsistency of Estimates 
Considerably different estimates of the average economic loss per case of 
CM were obtained in Papers II and IV. These figures are, however, not 
directly comparable. The model in Paper IV was a development of that in 
Paper II and there were, consequently, some differences in the underlying 
assumptions. All of these contributed to the lower estimate of average 
economic loss per case of CM obtained in Paper IV. 
The cost of extra labour requirement associated with treatment of CM 
was included in the fixed economic loss per case of CM (veterinary and 
treatment costs) in Paper II, but not in Paper IV. Which approach that is 
most correct depends on the assumed opportunity cost of labour, which, in 
turn, depends on the source of labour. Whether or not extra labour has 
been included in the economic loss caused by mastitis in previous studies 
has, indeed, varied (Table 4). SimHerd does not consider labour as a variable 
cost (Østergaard et al., 2005), and we, therefore, found it most suitable not   47 
to include extra labour requirement in the economic loss associated with 
CM when the economic parameters were updated for the analyses 
conducted in Paper IV.  
Milk sorted out due to high SCC was produced by cows without CM, 
and such milk was modelled to be fed to calves, thus, reducing the need for 
milk replacer. It was, consequently, assigned alternative value. SimHerd did 
not distinguish between this milk and milk not sold due to treatment of 
CM. As a result of this, milk produced in the withdrawal period was 
assigned alternative value in Paper IV, but not in Paper II. In this context, it 
needs to be stressed that feeding milk produced by cows receiving treatment 
to calves is not a recommended practice, because it increases antibiotic 
resistant bacteria in the lower gut of calves (Langford et al., 2003). 
Another, and probably the most important, explanation for the 
differences is that Paper II addressed the impact of the first lactational 
incidence of CM whereas Paper IV considered recurrent cases within the 
same lactation. When multiple cases developed, yield loss was defined based 
only on the impact of the most recent case. For instance, if a cow developed 
CM in lactation week two, and then again in lactation week four, the yield 
loss in lactation week five would be related only to the case occurring in 
lactation week four. The case developing in lactation week two would, 
thus, only incur yield loss in lactation weeks two and three. As a 
consequence, the average yield loss per case of CM was lower in Paper IV, 
551 kg ECM, as compared with 797 kg ECM in Paper II. Considering that 
the average price per delivered kg ECM was €0.288 in Paper IV, the value 
of a 246 kg ECM lower yield reduction equates to €71. If the average yield 
loss would have been the same in Paper IV as in Paper II, €71 should be 
added to the estimated average economic loss per case of CM, and a new 
estimate of €346 (compared with €428 in Paper II) would be arrived at. 
Also, yield loss in the weeks before clinical onset was attributed to CM in 
Paper II. This effect was assumed to be caused by SCM in Paper IV and 
was, thus, not included in the yield loss caused by CM. 
Based on these arguments, it is relatively safe to assume that the actual 
average economic loss per case of CM lies somewhere between €275 and 
€428. The former estimate was, however, derived from a more complete 
model, where recurrent cases of CM as well as SCM were adjusted for. The 
importance of representing effects of both CM and SCM when assessing the 
impact of mastitis in a dairy herd is stressed by the fact that estimates of net 
return per cow-year are highly sensitive to the severity of mastitis cases 
(Østergaard et al., 2005), and by subclinical cases being responsible for a 
large proportion of the total economic loss associated with mastitis (Huijps et   48
al., 2008; Yalcin, 2000). The estimate obtained in Paper IV is, consequently, 
likely to be more correct and the average economic loss of a case of CM 
will, in the remaining sections, be assumed to be €275.  
Consistency with Previously Published Estimates 
Estimates of the cost per case of mastitis, published since 1990, are 
summarized in Table 3. The average estimate is presented when studies 
reported several estimates. Studies based on old data (e.g. McInerney et al., 
1992) or concerning non-lactating cows (Hillerton et al., 1992) are not 
included. Estimates have been adjusted for the effect of inflation by the use 
of consumer price indices (Organization for Economic Co-operation and 
Development, 2009) and are expressed in the price level of 2007, which 
agrees with the price level applied in Paper IV. Estimates originally 
expressed in other currencies have been converted to Euro (exchange rate of 
18 November 2008, Paper IV) to facilitate comparison of results.  
 
Table 3. Estimates, published since 1990, of the cost per case of clinical (CM) and subclinical mastitis 
(SCM) in lactating cows 
Reference Country  Severity  Method  Cost per case (€) 
Paper IV  Sweden  CM  SS
1 275 
Paper II  Sweden  CM  SS  413 
Bar et al. (2008b)  US  CM  DP
2 146 
Huijps et al. (2008)  The Netherlands  CM  PB
3 205 
Wolfová et al. (2006)  Czech Republic  CM  PB  71 
Østergaard et al. (2005)  Denmark  CM
4 SS  360 
Kossaibati & Esslemont (1997)  UK  CM
5 PB  519 
Sandgren & Emanuelson (1994)  Sweden  CM  PB  350 
Miller et al. (1993)  US  CM  PB  142 
Belotti (1991)  Sweden  CM
4 PB  420 
        
Paper IV  Sweden  SCM  SS  60 
Steeneveld et al. (2007)  The Netherlands  SCM
6 SS  115
7 
Swinkels et al. (2005a)  The Netherlands  SCM
8 PB  116 
Swinkels et al. (2005b)  The Netherlands  SCM
6,9 PB  130 
1Stochastic simulation; 
2dynamic programming; 
3partial budget; 
4assuming that SCM is a natural       
part of CM;
 5severe case; 
6Streptococcus uberis; 
7without treatment; 
8Staphylococcus aureus; 
9Streptococcus 
dysgalactiae.  
The cost per case of mastitis differed between studies: estimates of the cost 
of a case of CM ranged between €71 and €519. Thus, compared to findings   49 
in the literature, the average economic loss of €275 per case of CM 
obtained in Paper IV is a relatively intermediate value.  
Cost components included in the total cost of mastitis differed widely 
between studies (Table 4), which probably explains a substantial part of the 
large variation in estimates. Veterinary costs, drugs, discarded milk, yield 
loss, and culling were frequently included, whereas other cost components, 
such as effects on milk composition, mortality, and spread of infection to 
healthy cows, were more infrequently accounted for. None of the reviewed 
studies considered increased risk of subsequent disorders (other than mastitis) 
or reduced fertility. 
 
Table 4. Cost components considered in studies, published since 1990, estimating the cost of mastitis in 
lactating cows  
  Considered consequences of mastitis 
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Paper IV
1  X  X  X  X X X    X  X  X     
Paper  II  X  X  X  X X X X X  X       
Bar et al. (2008b)    X  X  X      X  X  (X)
2 (X)
2    
Huijps et al.  (2008)  X X X X  X  X   X       
Wolfová et al.  (2006)  X  X  X     X         X
3 
Østergaard et al.  (2005)  X  X  X  X X X    X  X  X     
Kossaibati & Esslemont (1997)  X  X  X  X          X       
Sandgren & Emanuelson (1994)  X  X  X        X    X       
Miller et al.  (1993)  X X  X X    X  X X       
Belotti (1991)  X X X X  X  X   X       
                   
Paper IV
4        X X X    X  X  X     
Steeneveld et al. (2007)
5  X
6 X
6 X
6  X      X   X   
Swinkels et al. (2005a)   X
6 X
6  X      X    
Swinkels et al.  (2005b)       X      X   X   
1Clinical mastitis; 
2not included in cost, but accounted for in model; 
3dry-cow therapy;
 4subclinical 
mastitis; 
5without treatment; 
6applicable to clinical flare-up. 
Earlier Swedish studies have arrived at higher estimates of the economic loss 
per case of CM than Paper IV. These investigations used a simpler analytical 
approach, partial budgeting, and herd dynamics were, consequently, 
neglected. Differences are likely to arise as a consequence of dissimilar   50
analytical approaches applied. It has been pointed out (Bar et al., 2008b), 
that static models, such as partial budgets, often overestimate the economic 
loss associated with an average case of mastitis. The cost of mastitis is not the 
same in all cows, even if they are of the same parity and develop mastitis in 
the same stage of lactation. Mastitis affecting a cow that should be replaced 
anyway is, in practice, associated with a lower cost, whereas mastitis in cows 
of high future expected income is more costly (Bar et al., 2008b). The 
expected value of a mastitic cow will influence whether she receives 
treatment, which, in turn, will affect the magnitude of yield loss suffered. 
Dynamic models, therefore, often include a lower average yield loss per case 
of mastitis. Culling of mastitic cows is, to a large extent, a voluntary decision 
made by the farmer, and depends on the lactational timing of CM and 
pregnancy status of the cow (Schneider et al., 2007). Such interactions are 
not easily accounted for in static models. Static models attributing treatment 
costs, yield loss, and costs associated with increased risk of culling to every 
case of mastitis might, thus, overestimate the economic loss. 
It is difficult to make unbiased inferences about the impact of 
methodology on estimated cost per case of mastitis based on the summarized 
studies, because most of them obtained their estimates by means of partial 
budgeting. Studies applying stochastic simulation or dynamic programming 
arrived at estimates that fell within the range of estimates in studies using 
partial budgeting, and variability was thus larger within a specific analytical 
approach than between analytical approaches. Other factors, such as the 
economic value assigned to each component of loss included in the cost per 
case of mastitis, therefore seemed to be more important than the analytical 
approach applied. 
Estimates of the cost per case of CM in Western Europe were higher 
than those in the US, which was somewhat unexpected due to the absence 
of a milk-quota system in the US. Mastitis is more costly in a non-quota 
situation, because the reduction in milk yield subsequent to mastitis directly 
affects herd net returns by means of reduced milk sales. Where a quota 
system is in place, farmers usually compensate the lower average production 
brought about by mastitis with keeping cows in the herd beyond their 
intended culling date (Swinkels et al., 2005a). In Papers II and IV, no milk 
quota was modelled even though it is well known that the economic loss 
associated with mastitis depends on the presence or absence of a milk quota, 
and despite the fact that milk is produced under a quota system in Sweden. 
The amount of milk produced in Sweden is, however, not enough to fill 
the quota (Swedish Dairy Association, 2009), and Swedish milk production, 
thus, functions as if no milk quota was present.    51 
Differences between studies conducted in different spatiotemporal 
contexts can, at least to some extent, also be explained by different pathogen 
frequencies.  For instance, CM caused by environmental pathogens 
(primarily E. coli) have been reported to be more costly than CM caused by 
contagious pathogens (Miller et al., 1993). Swinkels et al. (2005a; 2005b) 
did, however, estimate relatively similar cost per case of SCM, irrespectively 
of whether Staph. aureus, Strept. uberis or Strept. dysgalactiae was the causative 
agent.  
Different circumstances of production, management routines, and 
attitudes towards the use of antibiotics are other factors likely to contribute 
to differences between estimates obtained in different countries. Likewise, 
prices and costs can be expected to differ. Indeed, the cost per case of CM 
has been found to depend on exogenous factors, primarily the milk price 
(Bar et al., 2008b): when a 20% higher milk price was modelled an 18% 
higher cost per case of CM was reported. 
All reviewed studies investigating the cost per case of SCM originated 
from the Netherlands and were conducted closely in time (Table 3). They 
also arrived at very similar estimates. The estimate of €60 per average case of 
SCM obtained in Paper IV was about half the size compared with those 
calculated by Steeneveld et al. (2007) and Swinkels et al. (2005a; 2005b). 
These studies investigated the cost of SCM caused by specific pathogens, 
whereas Paper IV did not take the causative pathogen into account. More 
importantly, different definitions of SCM were applied. In the three Dutch 
studies, SCM was defined as two out of three consecutive milk samples, 
taken at 3 or 4-week intervals, with SCC > 250  000 cells/ml. This 
definition requires that SCC is elevated for at least seven weeks, and, if it 
were to be applied in Paper IV, no cases of SCM would have occurred in 
primiparous cows because of the insufficient response in SCC. Modelled 
cases of SCM in Paper IV were, consequently, milder than those 
investigated by Steeneveld et al. (2007) and Swinkels et al. (2005a; 2005b), 
and a lower estimate of average economic loss per case is, thus, reasonable. 
Economic Loss caused by Mastitis in Sweden 
There are 350 000 dairy cows in Sweden (Swedish Board of Agriculture, 
2008a). Considering the estimated avoidable cost of mastitis of €54 per 
cow-year (Paper IV), the national avoidable cost can roughly be estimated at 
€19 millions per year. This figure does not include costs of prevention and 
costs that mastitis incurs to the processing industry. It is thus not an estimate 
of the total cost of mastitis, and, as such, it must be interpreted with care.   52
The proposed estimate does, however, give a hint of the extent of the 
economic damage caused by mastitis each year.  
No comparison of the national economic costs due to different 
production diseases in cattle has been conducted under Swedish 
circumstances of production. A British study (Bennett et al., 1999) has, 
however, investigated the economic impact of numerous diseases 
simultaneously, and came to the conclusion that mastitis, because of its high 
incidence and high financial impact per affected cow, had the largest 
economic impact on cattle production in the UK. 
Discarding Milk with High SCC  
The possibility that discarding milk with high SCC could reduce the 
economic loss associated with mastitis in dairy herds was refuted in Paper 
IV. Discarding milk with high SCC was never profitable in herds with 
average BTSCC between 158 000 and 236 000 cells/ml, because substantial 
amounts of milk had to be discarded. That generated an economic loss that 
was not offset by the increase in the milk price. It should be pointed out 
that discarding milk with high SCC was not economically justified, even 
though the discarded milk was assigned alternative value and extra labour 
costs were neglected. If discarded milk were not fed to calves, or if sorting 
of milk would require some monitoring, then the impact of discarding milk 
with high SCC would have been even more negative. 
The results of Paper IV suggest that the quality of delivered milk has less 
impact on herd net return than the amount of delivered milk, supporting 
the findings of Hansson (2007) who concluded that milk quality was not a 
significant indicator of economic performance in Swedish dairy herds 
whereas milk yield per cow was. The current Swedish milk-pricing system 
does, consequently, not serve as a strong motivation to discard milk with 
high SCC. Premiums and penalties are, however, an important motivation 
for farmers to improve udder health management (Valeeva et al., 2007), and 
the current milk-pricing system is, thus, likely to stimulate efforts to reduce 
BTSCC. Some concerns regarding the current milk-pricing system are, 
nevertheless, raised by the fact that the impact of discarding milk with high 
SCC on net return per cow-year was most negative when the incidence of 
mastitis was high. The extra premiums received when delivering milk with 
lower SCC did not compensate for the economic loss incurred by 
discarding milk. If the milk-pricing system is supposed to serve as an 
incentive to farmers to improve the quality of delivered milk, then 
premiums and penalties need to be revised. This, of course, invokes the   53 
issue of designing a new milk-payment scheme that would make it 
profitable to discard milk with high SCC. It needs to be stressed that it is 
not recommended to proceed with making changes in the milk-pricing 
system until scientifically supported regulatory limits have been proposed. 
Methodological Issues 
Reference Level for Yield in Healthy Cows 
Cows that develop CM tend to have a production advantage over non-
mastitic cows before diagnosis  (Gröhn et al., 2004; Wilson et al., 2004; 
Rajala-Schultz et al., 1999b). In Paper I, the seemingly higher 305-day 
yields of cows developing CM in mid or late lactation were most certainly a 
consequence of mastitic cows producing above the level of non-mastitic 
cows to such an extent that their cumulative 305-day yields were higher, 
even though they had suffered from CM towards the end of lactation. 
Therefore, using the yield of non-mastitic cows as the reference for 
production in healthy cows will underestimate the true yield loss caused by 
CM. 
In future studies aiming at assessing the impact of mastitis on milk yield, 
it is recommended to account for the higher initial milk yields of mastitic 
cows. One means to do this is to express yield loss relative to cows’ pre-
mastitic milk yield. This approach does, however, impose problems because 
most cases of CM develop in early lactation where no information on pre-
mastitic yield is available. This can, to some extent, be overcome by using 
the yield level in the previous lactation(s) for multiparous cows, and 
accounting for the expected yield change to this lactation. An appealing 
possibility would be to correct for a cow’s genetic and permanent 
environmental effect for milk-yield in the models, and, thus, obtain 
estimates that are less biased due to the relation between milk yield and 
mastitis. 
Recurrent Cases of CM 
Cows that have suffered from a case of mastitis are at increased risk of 
developing subsequent cases (Rajala & Gröhn, 1998; Houben et al., 1993). 
Still, the average number of CM cases per lactation was only 1.3 in the 
dataset studied in Paper I. Only the impact of the first lactational incidence 
of CM was, however, studied. By only including the first incidence, the 
entire lactational yield loss was attributed to just one case. Thus, in lactations 
with recurrent cases, the loss assigned to the first case will be overestimated. 
To obtain less biased estimates of the yield loss caused by a single case of   54
CM, lactations with multiple cases could have been excluded from the 
analyses.  
Estimates of Yield Loss Obtained from One Herd 
Yield losses estimated in Papers I and III were based on a dataset sampled in 
only one herd. In comparison with average Swedish figures, the herd has 
low BTSCC but high incidence of CM.  The studied herd was, however, a 
research herd, and the surveillance of animals was probably more extensive 
than what can be expected in commercial dairy herds. As a consequence of 
this, more CM cases than normally were likely detected. Also, some of the 
reported cases were presumably milder than those reported by practicing 
veterinarians, which might have influenced the size of the estimated yield 
loss. The estimates obtained in Paper I can, therefore, be utilized in 
decision-support without any risk of overestimating the yield loss caused by 
CM. 
Among the pathogens present in culture-positive milk samples taken in 
the research herd, a relatively large proportion was of environmental origin. 
As different pathogens give rise to different extent of yield loss, it might be 
argued that the estimates are not applicable in the average Swedish herd, 
where environmental pathogens, generally, are less frequent (Persson Waller 
et al., 2009). The sampling procedure in the research herd can, however, 
not be compared with that applied in commercial herds. Milk samples for 
bacteriological culture were collected by routine at pre-determined weeks in 
lactation, and not only when clinical symptoms were observed or when 
cows were suspected to be subclinically infected. It may be speculated that 
the bacteriological findings do, indeed, represent a pattern of infection that 
is representative also in other herds, but that is currently undetected due to 
the way in which sampling normally is conducted. 
Definition of SCM 
From a management perspective, estimates of the lactational yield loss 
caused by SCM occurring in different stages of lactation would have been of 
great interest, because such information could provide insight into the 
expected economic benefit that could be achieved if proper actions were 
taken. In order to obtain such estimates, however, a definition of a case of 
SCM would have been required. Subclinical mastitis does, by definition, not 
give rise to visible symptoms, and cannot be diagnosed by the milkers. 
Instead, SCM is defined based on SCC or other indicators. SCC is measured 
on a continuous scale, and, even though SCM is a dynamic condition,   55 
different threshold values are usually used to distinguish between healthy 
and affected cows. 
In Paper III, a threshold of 50 000 cells/ml was used to distinguish 
between healthy TD and TD affected by SCM in lactation weeks 2 to 44. 
This threshold was suggested by Hortet and Seegers (1998a), and was based 
on a review of studies on SCC in bacteriologically negative cultures; i.e. 
Laevens et al. (1997) who reported an SCC of 49 000 cells/ml in composite 
milk samples and Schepers et al. (1997) who found SCC around 14 000 
cells/ml in udder quarter foremilk samples. Higher thresholds of 175 000 
and 200 000 cells/ml in primiparous and multiparous cows, respectively, 
were applied in the first week of lactation (Paper III), because SCC is 
elevated in the colostrum period irrespective of whether the cow is affected 
with mastitis or not (Dohoo & Meek, 1982). These thresholds were defined 
based on bacteriological cultures of milk samples, taken by routine in the 
research herd in the first week of lactation from the fall of 1997. 
A threshold of 200 000 cells/ml is commonly applied to distinguish 
between healthy cows and cows affected by SCM. With respect to the 
findings of the previously mentioned studies, such a threshold is far too 
high. Also, the results obtained in Paper III indicate that milk yield is 
reduced on TD with an SCC of 200 000 cells/ml, as compared to TD with 
an SCC of 50 000 cells/ml. Applying a threshold of 200 000 cells/ml will, 
consequently, result in that the importance of SCM is underestimated, and 
that proper measures are not taken to avoid unnecessary milk loss in affected 
cows.  
A clear drawback with a definition of SCM based only on SCC at a 
single TD is that SCC is affected by a number of factors. Infectious status of 
the mammary gland is clearly the most important one, but season, stress and 
management mishaps also assert an effect on SCC (Reneau, 1986; Dohoo & 
Meek, 1982). Individual TD results are therefore rather inconclusive.  
In order to increase the accuracy of diagnosis, it has been suggested (De 
Haas et al., 2004; Reneau, 1986; Dohoo & Meek, 1982) that SCM should 
be defined based on measurements of SCC taken over a series of 
consecutive TD. In Sweden, “udder disease status”, based on SCC 
measured at three monthly test milkings, is used as a prognostic tool to 
identify individual cows that are likely to be affected by infectious mastitis 
(Brolund, 1985). De Haas et al. (2004) derived the SCC-patterns of 
clinically infected cows based on 3 to 5 TD results, recorded with intervals 
of three or four weeks. With such long sampling intervals, actually detecting 
an increased SCC will depend on when, with respect to sampling, infection 
occurred, but also on the duration of the increase in SCC, as pointed out by   56
De Haas et al. (2004). If this method were to be applied to SCM, subclinical 
infections could cure spontaneously or turn into a clinical infection before 
diagnosis based on a completed SCC-pattern could be made. A shorter time 
interval between TD is, thus, preferable if diagnosis of SCM is to be based 
on SCC-patterns. Patterns should preferably be based on daily observations, 
because SCC fluctuates from day to day (Reneau, 1986), and even between 
between milkings on the same day (Olde Riekerink et al., 2007b). 
Strategies for Modelling Yield Loss 
Using specific yield-loss patterns for different periods in lactation or just one 
yield-loss pattern, irrespective of the lactational timing of CM, only 
marginally affected the estimated economic impact of CM (Paper II). This 
was particularly evident when mastitic cows’ own yield level, had they not 
developed CM, was used as reference for production of healthy cows when 
yield losses were estimated. The lack of effect of modelling strategy on 
average economic loss per case of CM was probably due to that the average 
yield loss did not change much as most CM cases were modelled to occur in 
early and late lactation. In these periods, yield loss modelled by specific 
yield-loss patterns in different periods of lactation was higher and lower, 
respectively, compared with the yield loss modelled when one yield-loss 
pattern was used throughout lactation. This is likely to have evened out any 
difference between the modelling approaches. 
The results of Paper II, consequently, suggest that using one yield-loss 
pattern, irrespective of when in lactation CM occurs, is good enough, and 
that this approach to assess yield loss is adequate for application into 
decision-support systems. 
Method of Economic Analysis 
The analytical approach is often suggested to be one of the reasons for the 
variation in estimates of cost of mastitis obtained in different studies. The 
aim of the studies reviewed earlier was to estimate the cost of mastitis, and 
none of them, therefore, investigated a possible impact of methodology on 
the result. Stochastic modelling is suggested to be the most relevant method 
for assessment of economic impact of disease in dairy cattle because of its 
capability to account for herd dynamics. Simulation models are, however, 
not transparent, and are therefore not a very appealing tool for advisors. 
Partial budgets, on the other hand, are transparent, but are sometimes 
argued not to provide reliable estimates because of their inability to account 
for stochastic or dynamic elements.    57 
Paper II provided estimates of the average economic loss per case of CM 
estimated by stochastic simulation. To provide some insight into the impact 
of methodology on economic loss per case of CM, the economic loss of a 
case of CM will now be calculated using a simple partial budgeting 
approach. As far as possible, cost components will be assigned the same 
values as in Paper II. The estimate obtained in Paper II applied to an average 
case of CM. The extent of yield loss caused by CM shows large variation 
depending on in which week of lactation the cow is diseased (Paper I). In 
the partial budget analysis it is therefore assumed that CM occurred in the 
first lactation week, because this was the week in which most cows 
developed CM in the dataset used in Paper I. Furthermore, as most cows in 
Paper II (65%) were simulated to be in their second or later parity, the 
economic loss of a case of CM in a multiparous cow is estimated.  
 
Extra Costs  
When a cow is diagnosed with CM and treatment is necessary, a 
veterinarian is consulted (required by Swedish legislation). An average fixed 
cost of €133 per case, including extra labour requirement, veterinary costs 
and drugs, was assumed. Clinical mastitis increases the risk of culling, and, 
thus, incurs replacement costs. In previous studies, it has been assumed that 
15 to 20% of CM cases result in culling (Huijps et al., 2008; Sandgren & 
Emanuelson, 1994). The cost of culling can, roughly, be estimated as the 
cost of a replacement heifer minus the slaughter value of the culled cow. 
The value of a heifer is €952, and the meat from a slaughtered cow 
generates an income of €0.86 per kg live weight. Assuming that 15% of CM 
cases leads to culling and that live weight is 630 kg, extra costs associated 
with increased culling can be calculated as 0.15 x (€952 - €0.86 x 630) = 
€62. Extra costs associated with a case of CM in a multiparous cow in 
lactation week one are, consequently, €133 + €62 = €195. 
There are a couple of other aspects as regards culling due to mastitis that 
ought to be considered. Replacement animals are almost exclusively heifers, 
and primiparous cows have lower lactational milk yields than multiparous 
cows. By replacing an older cow with a younger, the production advantage 
of the older cow is lost. The value of the extra volume of milk that would 
have been produced if the older cow had not been culled should be 
included in the economic loss caused by CM. On the other hand, a heifer is 
on average genetically superior to the culled cow. Finally, a heifer is not 
always available when a cow must be replaced. If so, a stall will be empty 
and the production potential of the herd will not be fully utilized. It might 
be argued that the loss in income as a consequence of reduced capacity   58
utilization should be attributed to CM. These considerations will, however, 
be ignored for reasons of simplicity. 
 
Returns Foregone  
A multiparous cow developing CM in the first week of lactation suffers a 
yield loss of   782 kg milk (Paper I). Considering an average price per kg milk 
of €0.29, the economic loss caused by reduced milk yield amounts to €227. 
When the cow is diagnosed with mastitis, she receives antibiotics. Neither 
the milk produced during the treatment period nor the milk produced 
during the waiting period following treatment can be sold. The total 
withdrawal period subsequent to treatment usually lasts for eight days. The 
average daily milk yield in a multiparous cow diagnosed with CM in the 
first week of lactation is about 17 kg (Paper I), and the cost of the discarded 
milk is, consequently, €39. This is actually an underestimation of its 
economic value, because discarded milk is produced by the cow and is, 
consequently, associated with feed costs. The value of discarded milk is, 
thus, higher than that of lost milk yield. In spite of this, all milk not 
delivered will now be assigned the same value, resulting in an economic loss 
caused by returns foregone of €227 + €39 = €266. 
 
Additional Returns 
Milk produced in the withdrawal period is sometimes fed to calves. In this 
case, the discarded milk has an alternative value corresponding to the value 
of the milk replacer saved. The economic loss associated with discarded milk 
would then, obviously, be less. Feeding milk produced by cows treated with 
antibiotics is, however, not recommended and discarded milk will not be 
assumed to have an economic value. 
 
Reduced Costs  
When cows are affected by CM, feed intake is reduced (Bareille et al., 
2003). Østergaard et al. (2005), for instance, modelled a reduction of feed 
intake of 7, 5, and 2%, respectively, in the three weeks following CM 
diagnosis. The amount of money saved from reduced feed intake is, 
however, difficult to assess, because it will depend on the feedstuffs used, 
and will be neglected here.  
 
Consequences Not Considered 
Extra labour requirement and the increased risk of mortality caused by CM 
are not accounted for, and these factors were also not included in Paper II. 
Effects of CM on milk composition were not included, because it has been 
argued (Seegers et al., 2003) that changes in fat and protein content can be   59 
neglected in economic calculations as milk produced in the withdrawal 
period is discarded and losses occurring later in lactation are proportional to 
the milk loss. Also, increased SCC is not considered as BTSCC and the 
amount of milk produced in the herd will influence whether or not a case 
of CM affects milk price (Østerås, 2005).  
In this simple partial budgeting approach, an economic loss of €461 per 
case of CM was estimated. This figure is similar to the estimate of €428 
obtained in Paper II, supporting the notion that the value assigned to each 
cost component is more influential on the estimate than the analytical 
approach. A well-parameterized partial budget is, therefore, able to provide 
reliable estimates of the economic loss associated with production disorders. 
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Main Conclusions 
The yearly avoidable cost of mastitis in a Swedish 150-cow dairy herd, 
assuming that the initial incidence (32 and 33 cases of CM and SCM per 
100 cow-years, respectively) can be reduced by 50%, is slightly more than 
€8 000. This figure corresponds to 5% of the net return given the initial 
incidence of mastitis. Expressed per cow/year, the avoidable cost of mastitis 
is €50.  
The economic loss associated with mastitis cannot be reduced by 
discarding milk with high SCC, because this resulted in a substantial 
decrease of the volume of sold milk, which was not offset by the increase in 
milk price. Under the current milk-pricing system, it is, consequently, more 
profitable for farmers to sell a larger volume of milk with higher SCC than 
to discard high SCC milk in order to obtain a higher average milk price.  
The average economic loss per case of CM and SCM are €275 and €60, 
respectively. Reduced milk production constitutes the major cost 
component of the total economic loss caused by mastitis. The magnitude of 
yield loss is determined by the stage of lactation in which the cow develops 
mastitis: milk yield is most severely affected when CM occurs in early and 
when SCM occurs in late lactation. The lactational yield loss associated with 
CM varies between 0 and 705 kg in primiparous cows and between 0 and 
902 kg in multiparous cows, depending on lactation week at clinical onset. 
Most cases of CM develop in the first week of lactation and results in a yield 
loss of 578 and 782 kg milk in primiparous and multiparous cows, 
respectively. This yield loss is, most likely, underestimated, because it is 
expressed relative to the production level of non-mastitic cows, and cows 
developing CM tends to have a production advantage over non-mastitic 
herd mates before becoming diseased. Daily milk loss at an SCC of 500 000 
cells/ml amounts to 0.7 to 2.0 kg in primiparous cows and 1.1 to 3.7 kg in 
multiparous cows in different stages of lactation. SCM is difficult to define   62
accurately, and the impact of SCM on milk yield was, therefore, assessed in 
terms of increased SCC. No estimates of the lactational yield loss caused by 
a case of SCM could, consequently, be obtained. The yield loss in an average 
305-day lactation affected by SCM is, however, 150 and 450 kg milk in 
primiparous and multiparous cows, respectively.  
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Practical Implications 
This thesis clearly demonstrates that the economic performance of dairy 
herds can be improved by reducing the incidence of mastitis. A lower 
incidence of mastitis can be achieved by implementation of mastitis control 
programs. In order to make scientifically supported decisions regarding 
mastitis control in dairy herds, however, accurate estimates of the avoidable 
cost of mastitis are a necessary prerequisite. These are provided in this thesis. 
The negative economic consequences of mastitis can be reduced either 
by preventing new cases from occurring or by strategies aiming to limit the 
impact of mastitis once it has occurred. It is demonstrated that prevention is 
preferred over discarding milk with high SCC, because a reduction of the 
incidence of mastitis resulted in significantly increased net return per cow-
year, whereas the effects of discarding milk with high SCC seemed to be 
poor. Farmers are, therefore, recommended to invest in preventive measures 
rather than in milk-sorting equipment.   
The largest proportion of economic loss associated with mastitis arises 
from reduced milk production. Yield loss is, however, a hidden cost and it is 
not always obvious to farmers. It is, therefore, the task of advisors to 
communicate the relative economic importance of lost milk production, as 
compared to veterinary costs, and to convey that veterinary costs are to be 
regarded as a means to limit the potentially more severe economic loss 
caused by reduced milk production.  
Considering that most cows in a herd are of second or later parities and 
that the incidence of CM, as well as the proportion of TD with increased 
SCC, is highest in multiparous cows, the majority of the production loss 
caused by mastitis is likely to be experienced by multiparous cows. Special 
emphasis should, therefore, be put on reducing the incidence of mastitis in 
multiparous cows. This can be attempted by enhanced mastitis control in 
primiparous cows, because cows that have suffered from mastitis are more   64
likely to develop subsequent cases. Attention should be paid to cows in early 
and late stages of lactation. During these periods, the incidence of mastitis is 
highest and yield losses are most severe, but, by taking proper actions, 
unnecessary milk loss can be avoided. High-yielding cows should be given 
priority, because they are at increased risk of developing CM.  
Partial budgets are relatively easy to construct and are able to provide 
accurate estimates of the economic impact of disease. If reliable information 
on the effects of disease and the value of cost components are available, they 
can be used by advisors and farmers to support decisions regarding animal 
health management. 
The incidence of mastitis can be reduced by breeding for increased 
mastitis resistance. Genetically, CM is not the same trait over time and this 
should be considered in the genetic evaluation for mastitis resistance 
(Carlén, 2008). Based on the findings of this thesis, it might be economically 
wise to use a selection criterion which attaches more weight to CM in early 
lactation. 
The substantial economic loss associated with mastitis is a powerful 
incentive to improve the udder health of dairy cows, encouraging farmers to 
put effort into mastitis prevention. In a long-term perspective, this thesis 
can, therefore, result in improved welfare of dairy cows as it sheds light on 
the economic importance of mastitis. 
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Future Research 
The presented estimates of yield loss caused by mastitis were based on data 
sampled in a single herd, where production records sampled at weekly 
intervals were available. The validity of the results in herds with other 
production characteristics should be verified by repeating the analyses on 
data sampled in herds with different incidences of mastitis, yield levels, and 
pathogen frequencies.  
In Papers I and III, production records sampled at weekly intervals were 
used to estimate the magnitude of yield loss associated with mastitis. The 
obtained estimates were, consequently, more fine-tuned as compared with 
those presented in the literature, where similar studies usually have been 
conducted based on datasets collected at monthly samplings. As milking 
systems are becoming more and more technologically advanced, data 
collected even more frequent is becoming readily available. Based on data 
recorded on a daily basis, or even at individual milkings, the impact of 
mastitis on milk yield could be further dissected. Estimates obtained in such 
analyses would improve mastitis management, because farmers could make 
more well-informed decisions. 
An interesting topic to examine is a possible breed difference in the 
extent of yield loss suffered due to mastitis. Swedish Red cows have lower 
incidences of diseases than Swedish Holstein cows, which might indicate 
differences in innate immune function between the breeds. It may be 
speculated that a better immune function in Swedish Red cows can 
contribute also to less yield loss due to faster, and more complete, cure. The 
economic loss associated with mastitis might, consequently, not be the same 
in both breeds. Therefore, it is worth studying whether economic 
considerations actually favour the somewhat lower producing, but more 
robust, Swedish Red cow.      66
All strategies of mastitis control are not equally effective as regards their 
ability to increase the economic performance of dairy herds. The 
profitability of a certain preventive measure is determined by the cost of its 
implementation and the value of the reduction in mastitis incidence that it 
can achieve. In order to improve decision support concerning whether 
individual herds ought to invest in preventive measures and to facilitate 
prioritization between different strategies, the expected economic viability 
of different preventive measures should be investigated. 
There are technological tools, such as Herd Navigator
®, available on the 
market that enable detection of SCM at an early stage of infection and, thus, 
allow for early intervention. With early treatment of mastitis, cure rate can 
be expected to be higher and the economic loss can thereby be reduced. In 
theory, such equipment has the potential to revolutionize udder-health 
management. It is, however, associated with an investment of considerable 
magnitude, and research is required to assess the economic viability of this 
kind of technology. Preferably, economic calculations should consider the 
consequences of a, possibly, increased usage of antibiotics resulting from 
more cases of mastitis being detected. 
Discarding milk with high SCC was not an effective strategy to increase 
herd net return under the current milk-pricing system. The simulated herds 
did, however, have a relatively low BTSCC, and the impact of sorting of 
milk in herds with higher BTSCC and higher incidence of CM must also be 
looked into. If such studies confirm that discarding milk with high SCC is 
not profitable, an important task for research is to demonstrate the reduced 
product value of high-SCC milk. Such information can support decisions 
regarding whether the premium and penalty system needs to be revised, or 
if new regulatory limits with respect to SCC should be proposed, so that 
farmers are motivated not to deliver milk of poor quality. 
Because mastitis is considered the most costly disease affecting dairy 
cows, it is often prioritized in herd-health management. Other production-
related disorders, such as lameness, might as a result receive less attention, 
although they are responsible for substantial economic loss. In order to 
achieve correct on-farm prioritizations regarding disease control, effects of 
all disorders must be considered simultaneously. To take a comprehensive 
approach to herd-health management, the economic impact of lameness, 
metabolic disorders, reproductive disorders, and calving-related disorders, 
therefore, need to be assessed. In order to facilitate comparison between the 
obtained results and our estimates of economic loss caused by mastitis, such 
studies should be performed under Swedish production circumstances.    67 
Ekonomisk betydelse av mastit hos mjölkkor 
Bakgrund 
Mjölksektorn är utsatt för hårdnande internationell konkurrens. Ekonomiskt 
effektiva besättningar är därför en förutsättning för att en livskraftig svensk 
mjölkproduktion ska kunna upprätthållas. Detta medför att det blir allt 
viktigare att optimera produktionens alla delar och behovet av 
kostnadsminimering accentueras i takt med att produktvärdet minskar. Ett 
sätt att minska produktionskostnaderna är att reducera förekomsten av 
produktionssjukdomar, då dessa leder till reducerad avkastning, kostnader för 
veterinär och behandling samt ökad utslagning. I detta sammanhang är 
mastit (juverinflammation) av stor betydelse, eftersom sjukdomen är vanligt 
förekommande och ger upphov till stora ekonomiska förluster. I 
besättningar anslutna till kokontrollen förekommer mastit i 16 % av alla 
laktationer. Sjukdomen kan dock antas vara betydligt vanligare än så 
eftersom antalet mastiter som upptäcks av djurägare visat sig vara 33 % högre 
än antalet mastiter i djursjukdata. Juversjukdom, inklusive höga celltal (ett 
mått på den immunologiska aktiviteten i juvret), utgör den vanligaste 
utslagsorsaken bland svenska mjölkkor; i drygt en fjärdedel av fallen då kor 
gallras ut anges juversjukdom som orsak. Detta innebär att 10 % av den 
svenska mjölkkopopulationen årligen slås ut på grund av juversjukdom. 
Förutom rent ekonomiska förluster ger mastit upphov till ett flertal andra 
negativa påföljder. Sjukdomen medför en ökning av mjölkens celltal, vilket 
leder till sämre processegenskaper. Vidare förknippas mastit med försämrad 
djurvälfärd och ökad användning av antibiotika, vilket påverkar 
konsumenternas attityd gentemot mjölkproduktionen negativt. 
De ekonomiska konsekvenserna av mastit kan minskas genom åtgärder 
som syftar till att förebygga nya fall av mastit eller begränsa effekterna av 
mastiter då de inträffat. Sådana åtgärder innebär dock extra kostnader för   68
mjölkproducenten i form av produkter och arbete. En förutsättning för att 
investeringar ska göras är därför att dessa kan förväntas generera ökade 
intäkter som överstiger kostnaderna. Kunskap om den ekonomiska 
betydelsen av mastit är därför avgörande när lönsamheten av att investera i 
mastitprevention ska utvärderas. Vidare påverkar sådan information andra 
skötselbeslut i en besättning, t.ex. om en ko med mastit ska behandlas, 
sinläggas eller slås ut, samt om mjölk med högt celltal ska sorteras bort för att 
på så vis få ett högre pris för den levererade mjölken. På nationell nivå är 
uppgifter om kostnaden avgörande för t.ex. investeringar i bättre 
registreringar av mastit i kokontrollen och för att ge mastit rätt ekonomisk 
vikt i avelsmålet. 
Syftet med denna avhandling är att skatta kostnaden för mastit under 
svenska produktionsförhållanden. 
Sammanfattning av avhandlingens delarbeten 
Avkastningsförlusternas storlek 
Avkastningsförlustens storlek beror på när i laktationen kon får mastit. 
Klinisk mastit orsakar störst produktionsbortfall då korna insjuknar i början 
av laktationen, medan förhöjt celltal ger upphov till störst avkastningsförlust 
när det inträffar i slutet av laktationen. Avkastningsförlusterna är konsekvent 
högre hos äldre kor än hos förstakalvare. 
Klinisk mastit uppträder oftast i första laktationsveckan. Förstakalvare och 
äldre kor som diagnosticeras med klinisk mastit under den perioden drabbas 
av ett produktionsbortfall på 578 respektive 782 kg mjölk. Mjölkförlustens 
storlek varierar mellan 0 och 705 kg (0 till 9 %) hos förstakalvare och mellan 
0 och 902 kg (0 till 11 %) hos äldre kor, beroende på när mastiten 
uppträder. Den dagliga avkastningsförlusten vid ett celltal på 500  000 
celler/ml uppgår till 1 till 2 kg mjölk hos förstakalvare och 1 till 4 kg mjölk 
hos äldre kor, beroende på i vilket laktationsstadium som kon befinner sig. I 
en genomsnittlig laktation där subklinisk mastit förekommer reduceras 
avkastningen med 150 och 450 kg mjölk hos förstakalvare respektive äldre 
kor. 
Kostnad per fall 
Varje fall av klinisk mastit är i genomsnitt förknippat med en ekonomisk 
förlust motsvarande 2 800 kr, vilken i huvudsak utgörs av reducerad mjölk-
produktion. Ett fall av subklinisk mastit värderas i medeltal till 600 kr.    69 
Besättningsekonomiska konsekvenser 
Om den nuvarande förekomsten av mastit i en genomsnittlig svensk 150-
kors besättning halverades skulle täckningsbidraget öka med 80 000 kr per 
år, vilket motsvarar 5 % av täckningsbidraget. Detta belopp motsvarar den 
maximala årliga investeringen i mastitförebyggande åtgärder, och kan 
innebära t.ex. ytterligare 1,2 timmars lönekostnad per dag eller en 
investering om 580 000 kr i ny teknik. 
Sortering av mjölk för att sänka tankcelltalet 
Ett tänkbart sätt att reducera de besättningsekonomiska effekterna av mastit 
skulle kunna vara att sortera bort mjölk med högt celltal för att på så vis 
undvika betalningsavdrag. Flera olika tröskelvärden för sortering har 
undersökts, men samtliga hade negativ inverkan på täckningsbidraget 
eftersom en avsevärd mängd mjölk sorterades bort. Under det nuvarande 
mjölkbetalningssystemet är den levererade mjölkens kvantitet av större 
betydelse för besättningens ekonomiska resultat än dess kvalitet. 
Kostnaden för mastit i Sverige 
I Sverige finns ungefär 350 000 mjölkkor. Täckningsbidraget per ko och år 
är 550 kr lägre än vad det skulle ha varit om mastitfrekvensen hade varit 
hälften så hög som idag. På nationell nivå uppgår alltså den motsvarande 
ekonomiska förlusten på grund av mastit till 192 miljoner kr. Denna siffra 
innefattar inte kostnader för förebyggande åtgärder mot mastit. Om dessa 
hade inkluderats, vilket skulle varit mer korrekt, skulle den totala kostnaden 
för mastit varit högre. 
Slutsatser 
De viktigaste resultaten från avhandlingen kan summeras enligt följande: 
 
  Mastit kostar årligen Sveriges mjölkproducenter 192 miljoner kr 
  Kostnaden för mastit uppgår i genomsnitt till ca 550 kr per ko och 
år 
  En klinisk mastit kostar i genomsnitt ca 2 800 kr medan en 
subklinisk mastit i medeltal kostar ca 600 kr 
  De ekonomiska förlusterna p.g.a. mastit kan inte reduceras genom 
att mjölk med högt celltal sorteras bort 
  Den största kostnadsposten i samband med mastit är reducerad 
avkastning   70
  Klinisk mastit ger upphov till större avkastningsförlust än subklinisk 
mastit 
  Klinisk mastit orsakar högst avkastningsförluster hos kor som 
insjuknar tidigt i laktationen 
  Subklinisk mastit reducerar dygnsavkastningen mest då kor drabbas 
sent i laktationen 
  Mastit orsakar större avkastningsförlust hos äldre kor än hos 
förstakalvare 
  Kor drabbas oftast av klinisk mastit i första laktationsveckan 
  Hög mjölkproduktion är en riskfaktor för klinisk mastit 
Praktisk tillämpning av resultaten 
Det är tydligt att besättningars ekonomiska resultat kan förbättras genom att 
förekomsten av mastit reduceras. I en genomsnittlig svensk besättning kan 
550 kr per ko och år investeras i mastitprevention, under förutsättning att 
dagens mastitfrekvens därigenom halveras. Det inte lönsamt för lantbrukare 
att sortera bort mjölk med högt celltal. Lantbrukare rekommenderas därför 
istället att investera i mastitförebyggande åtgärder. Särskild vikt ska läggas vid 
att förhindra mastiter i tidig och sen laktation, eftersom flest kor insjuknar i 
dessa perioder och avkastningsförlusterna är som störst då.   71 
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